Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease
Open accessPublished version of a preprint
Abstract
Congenital heart defects constitute the most common human birth defect, however understanding of how these disorders originate is limited by our ability to model the human heart accurately in vitro. Here we report a method to generate developmentally relevant human heart organoids by self-assembly using human pluripotent stem cells. Our procedure is fully defined, efficient, reproducible, and compatible with high-content approaches. Organoids are generated through a three-step Wnt signaling modulation strategy using chemical inhibitors and growth factors. Heart organoids are comparable to age-matched human fetal cardiac tissues at the transcriptomic, structural, and cellular level. They develop sophisticated internal chambers with well-organized multi-lineage cardiac cell types, recapitulate heart field formation and atrioventricular specification, develop a complex vasculature, and exhibit robust functional activity. We also show that our organoid platform can recreate complex metabolic disorders associated with congenital heart defects, as demonstrated by an in vitro model of pregestational diabetes-induced congenital heart defects.
AI snapshot
Written from the paper’s full text.
TL;DR
The paper reports a fully defined, reproducible method to generate self-assembling human heart organoids (hHOs) from human pluripotent stem cells via three-step Wnt signaling modulation. The hHOs recapitulate fetal-like cardiac structure, multi-lineage composition, chamber formation, vascularization, and electrophysiology, and can model pregestational diabetes-induced congenital heart defects in vitro.
Key findings
- hHOs were generated by sequential CHIR99021/Wnt-C59/CHIR99021 treatment; beating appeared as early as day 6, was robust by day 10, and lasted at least 8 weeks. Optimal first Wnt activation was 1–4 µM CHIR99021, with 4 µM yielding 64.9 ± 5.3% TNNT2+ cells at day 15.
- hHOs contained multiple cardiac lineages: approximately 59% cardiomyocytes, 16% epicardial cells, 14% endocardial cells, 12% cardiac fibroblasts, and 1.6% endothelial cells; at day 15, atrial cardiomyocytes were ~48% and ventricular cardiomyocytes ~18% of total cells.
- hHOs formed 4–6 internal chambers ranging from 5.5e−4 mm3 to 1.3e−2 mm3, with organoid size up to 1 mm in diameter (~0.45 mm3), and showed vascular networks, action potentials, and calcium transients.
- In a pregestational diabetes model using 11.1 mM glucose and 1.14 nM insulin versus 3.5 mM glucose and 170 pM insulin, diabetic hHOs were larger, showed arrhythmic action potentials, decreased oxygen consumption, increased glycolysis, fewer mitochondria, more lipid droplets, decreased MYL2+ ventricular cells, enlarged MYL7+ atrial regions, and disrupted epicardial/myocardial organization.
Methods
- hPSCs were seeded at 10,000 cells/well in ultra-low attachment 96-well plates to form embryoid bodies, then differentiated with a three-step Wnt modulation protocol using CHIR99021, Wnt-C59, and a second CHIR99021 exposure; BMP4 and Activin A were tested as additives.
- Characterization included RNA sequencing across days 0–19, immunofluorescence/confocal imaging, optical coherence tomography, TEM, microelectrode array electrophysiology, GCaMP6f calcium imaging, and Seahorse metabolic assays.
- Statistical analysis used unpaired two-tailed Student’s t-tests and 1-way or 2-way ANOVA with multiple-comparison corrections; data are mean ± s.d. from at least 3 independent experiments unless otherwise stated.
Limitations
- Stated: organoids tend to deviate from normal developmental pathways over time and become less relevant the longer they are cultured; their recapitulation of heart development remains limited compared with models such as mice.
- Stated: the technology needs improvement in morphological/anatomical fidelity and in forming effective vascular networks that can provide nutrients; further studies are needed to assess vascular maturity, connectivity, and resemblance to coronary vasculature.
- Stated and evident: immunofluorescence and bulk RNA sequencing may not fully capture organoid heterogeneity, and single-cell/single-organoid omics are proposed for future work; the study is in vitro only and does not report in vivo validation or transplantation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 68 cited sources checked · 0 supported · 0 flagged
- Findingnone given
The hHO protocol relies mainly on three sequential Wnt modulation steps (activation/inhibition/activation) at specific time points on suspension embryoid bodies.
“Our protocol relies mainly on three sequential Wnt modulation steps (activation/inhibition/activation) at specific time points on suspension embryoid bodies (EBs)”
Quote in the paperSubstantial claim - Findingnone given
hHOs are comparable to age-matched human fetal cardiac tissues at the transcriptomic, structural, and cellular level.
“Heart organoids are comparable to age-matched human fetal cardiac tissues at the transcriptomic, structural, and cellular level.”
Quote in the paperSubstantial claim- Rests on an assumption: The developmental stage of hHOs at day 19 is age-matched to human fetal hearts at gestational days 57–67.
- Findingown data
hHOs develop sophisticated internal chambers with well-organized multi-lineage cardiac cell types.
“They develop sophisticated internal chambers with well-organized multi-lineage cardiac cell types”
Quote in the paperSubstantial claim - Findingown data
The paper reports a small molecule-based methodology to create highly complex and physiologically relevant self-assembling human heart organoids using hPSCs by manipulating cardiac developmental programs.
“Here we report a method to generate developmentally relevant human heart organoids by self-assembly using human pluripotent stem cells.”
- Also stated in: § Introduction · plain
“Here, we report a small molecule-based methodology to create highly complex and physiologically relevant self-assembling human heart organoids (hHOs) using hPSCs by manipulating cardiac developmental programs.”
Quote in the paperSubstantial claim - Also stated in: § Introduction · plain
- Findingnone given
The hHO protocol produces significant heart-like structures in terms of structure, organization, functionality, cardiac cell type complexity, ECM composition, and vascularization.
“produces significant heart-like structures in terms of structure, organization, functionality, cardiac cell type complexity, ECM composition, and vascularization.”
Quote in the paperSubstantial claim
- Findingown data
Brightfield and immunofluorescence imaging of hHOs showed a significant increase in size throughout the differentiation protocol.
“Brightfield and immunofluorescence imaging of hHOs showed a significant increase in size throughout the differentiation protocol”
Quote in the paperNot a substantial claim - Findingown data
Extracellular matrix proteins common in cardiac tissue, such as collagen type 1, collagen type 4, and fibronectin, were all observed in the hHO model.
“Lastly, extracellular matrix proteins common in cardiac tissue, such as collagen type 1, collagen type 4, and fibronectin, were all observed in our hHO model”
Quote in the paperNot a substantial claim - Findingown data
Principal component analysis showed a clear progression in development in the hHOs from day 0 to 19.
“Principal component analysis showed a clear progression in development in the hHOs from day 0 to 19”
Quote in the paperSubstantial claim - Findingown data
hHOs had higher cardiac cell lineage complexity than cells that underwent monolayer differentiation, especially in epicardial, endothelial, endocardial, and cardiac fibroblast populations.
“Gene expression profiles showed hHOs had higher cardiac cell lineage complexity than cells that underwent monolayer differentiation, especially in the epicardial, endothelial, endocardial, and cardiac fibroblast populations”
Quote in the paperSubstantial claim - Findingown data
Time-course RNA sequencing between days 0 and 19 revealed stepwise production of fundamental cardiac development morphogens and growth factors and their respective receptors.
“Time-course RNA sequencing analysis between days 0 and 19 of differentiation supports this hypothesis by revealing the stepwise production of fundamental cardiac development morphogens and growth factors and their respective receptors”
Quote in the paperSubstantial claim - Findingown data
Gene ontology biological process analysis identified important genetic circuitry driving cardiovascular development and heart formation.
“Gene ontology biological process analysis identified important genetic circuitry driving cardiovascular development and heart formation”
Quote in the paperSubstantial claim - Findingnone given
hHOs exhibit robust functional activity.
“exhibit robust functional activity”
Quote in the paperSubstantial claim - Findingnone given
hHOs develop a complex vasculature.
“develop a complex vasculature”
Quote in the paperSubstantial claim - Findingown data
Markers for pluripotency were not found in hHOs beyond day 1.
“Markers for pluripotency were not found in hHOs beyond day 1”
Quote in the paperSubstantial claim - Findingown data
A second Wnt activation step on differentiation days 7-9 robustly promoted the formation of proepicardium and epicardial cells on the organoid's surface.
“We found that the treatment robustly promoted the formation of proepicardium and epicardial cells (Fig. 1g; Supplementary Fig. 2a, b) on the organoid’s surface”
Quote in the paperSubstantial claim - Findingown data
A single 2 μM CHIR99021 exposure for 1 h on differentiation day 7 produced the most physiologically relevant epicardial to myocardial ratio (60-65% cardiomyocytes, 10-20% epicardial cells).
“A single 2 µM CHIR99021 exposure for 1 h on differentiation day 7 produced the most physiologically relevant epicardial to myocardial ratio (60–65% cardiomyocytes, 10–20% epicardial cells)”
Quote in the paperSubstantial claim - Findingown data
Optimal cardiogenic mesoderm induction for all hESC and hiPSC lines was found at 1-4 μM CHIR99021 concentrations, rather than the typical 10-12 μM range reported for monolayer methods.
“Optimal cardiogenic mesoderm induction for all human embryonic stem cell (hESC) and induced pluripotent stem cell (hiPSC) lines was found at 1–4 μM CHIR99021 concentrations, rather than the typical 10–12 µM range reported for monolayer methods14,21–27.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [14] Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372–E8381 (2017). source
Not checked in the free run.
- cites [21] Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162–175 (2013). source
Not checked in the free run.
- cites [22] Bao, X. et al. Long-term self-renewing human epicardial cells generated from pluripotent stem cells under defined xeno-free conditions. Nat. Biomed. Eng. 1, 1–12 (2017). source
Not checked in the free run.
- cites [23] Breckwoldt, K. et al. Differentiation of cardiomyocytes and generation of human engineered heart tissue. Nat. Protoc. 12, 1177–1197 (2017). source
Not checked in the free run.
- cites [24] Giacomelli, E., Mummery, C. L. & Bellin, M. Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes. Cell. Mol. Life Sci. 74, 3711–3739 (2017). source
Not checked in the free run.
- cites [25] Hoang, P., Wang, J., Conklin, B. R., Healy, K. E. & Ma, Z. Generation of spatial-patterned early-developing cardiac organoids using human pluripotent stem cells. Nat. Protoc. 13, 723–737 (2018). source
Not checked in the free run.
- cites [26] Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. USA 109, 1–10 (2012). source
Not checked in the free run.
- cites [27] Lian, X. et al. Chemically defined, albumin-free human cardiomyocyte generation. Nat. Methods 12, 595–596 (2015). source
Not checked in the free run.
- Findingown data
A significant part of the epicardial tissue was found on external layers of the organoid and adjacent to well-defined myocardial tissue, recapitulating the structural organization found in the heart.
“Structurally, a significant part of the epicardial tissue was found on external layers of the organoid and adjacent to well-defined myocardial tissue (TNNT2 + ) (Fig. 1g, Supplementary Fig. 2a, b), thus recapitulating the structural organization found in the heart.”
Quote in the paperSubstantial claim - Findingown data
hHOs treated with 4 μM CHIR99021 displayed the best functional properties out of all tested concentrations.
“hHOs treated with 4 µM CHIR99021 also displayed the best functional properties out of all tested concentrations”
Quote in the paperSubstantial claim - Findingown data
Higher magnification images uncovered a complex web of endothelial cells adjacent to or embedded in myocardial tissue.
“Higher magnification images uncovered a complex web of endothelial cells adjacent to or embedded in myocardial tissue”
Quote in the paperSubstantial claim - Findingown data
Unsupervised K-means clustering revealed organoids progressed through three main developmental stages: day 0-1 associated with pluripotency and early mesoderm commitment; day 3-7 associated with early cardiac development; and day 9-19 associated with fetal heart maturation.
“Unsupervised K-means clustering analysis revealed organoids progressed through three main developmental stages: day 0–day 1, associated with pluripotency and early mesoderm commitment; day 3–day 7, associated with early cardiac development; and day 9–day 19, associated with fetal heart maturation”
Quote in the paperSubstantial claim - Findingown data
Expression of heart-specific extracellular matrix genes was high in hHOs and fetal hearts but completely absent in monolayer differentiation protocols.
“Of special interest, expression of heart-specific extracellular matrix genes was high in hHOs and fetal hearts but completely absent in monolayer differentiation protocols”
Quote in the paperSubstantial claim - Findingown data
4 μM CHIR99021 exposure resulted in the highest cardiomyocyte content with 64.9 ± 5.3% TNNT2+ cells at day 15.
“4 µM CHIR99021 exposure resulted in the highest cardiomyocyte content with 64.9 ± 5.3% TNNT2 + cells at day 15”
Quote in the paperSubstantial claim - Findingown data
Immunofluorescence for NFATC1 revealed the formation of endocardial layers, similar to the endocardial lining of heart chambers.
“Immunofluorescence analysis for the endocardial marker NFATC1 (an endocardial specific cell marker19) revealed the formation of endocardial layers, similar to the endocardial lining of heart chambers”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Drakhlis, L. et al. Human heart-forming organoids recapitulate early heart and foregut development. Nat. Biotechnol. 39, 737–746 (2021). source
Not checked in the free run.
- Findingown data
Confocal imaging confirmed the presence of cardiac fibroblasts positive for THY1 and VIM, similar to the composition of the fetal heart.
“Confocal imaging confirmed the presence of cardiac fibroblasts positive for THY1 and VIM (Fig. 3a), similar to the composition of the fetal heart34.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34] Pinto, A. R. et al. Revisiting cardiac cellular composition alexander. Circ. Res. 118, 400–409 (2017). source
Not checked in the free run.
- Findingown data
Robust expression of TJP1 on epicardial cell membranes confirmed the epithelial phenotype of these cells.
“The robust expression of TJP1 on epicardial cell membranes also confirmed the epithelial phenotype of these cells”
Quote in the paperNot a substantial claim - Findingcitation
Non-myocyte cardiac cells were often intermixed within TNNT2+ myocyte regions as seen in vivo.
“It should be noted that these non-myocyte cardiac cells were often intermixed within TNNT2 + myocyte regions (Fig. 3a–e) as seen in vivo35.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [35] Scott F. & Gilbert, M. J. F. B. Lateral Plate Mesoderm: Heart and Circulatory System. In Developmental Biology 591–610 (Sinauer Associates is an imprint of Oxford University Press, 2019).
Not checked in the free run.
- Findingown data
BMP4/ActA treatment significantly increased chamber interconnectivity compared to control (p = 0.041).
“d Interconnectivity of chambers measured by their separation by thin TNNT2 + filaments or by thin channels showing clear connection (n = 10 organoids per condition, value = mean ± s.d., two-tailed, unpaired t-test, *p = 0.041).”
Quote in the paperSubstantial claim - Findingown data
Large central chamber-like structures surrounded by beating tissue were present in hHOs.
“This revealed the presence of large central chamber-like structures surrounded by beating tissue, as suggested before by confocal imaging”
Quote in the paperSubstantial claim - Findingown data
PGDHOs have decreased oxygen consumption rate compared to cells dissociated from NHOs.
“Metabolic assays for glycolysis and oxygen consumption revealed decreased oxygen consumption rate in PGDHOs and increased glycolysis when compared to cells dissociated from NHOs (Fig. 7d, e, Supplementary Fig. 8d).”
Quote in the paperSubstantial claim - Findingown data
No significant differences were found in the formation of myocardial (TNNT2+) or epicardial (WT1+/TJP1+) tissue between control and BMP4/Activin A-treated hHOs.
“No significant differences were found in the formation of myocardial (TNNT2+) or epicardial (WT1+/TJP1+) tissue between control and treated hHOs”
Quote in the paperNot a substantial claim - Findingown data
The hHO method consistently yields cardiac organoids with approximately 59% cardiomyocytes, 16% epicardial cells, 14% endocardial cells, 12% cardiac fibroblasts, and 1.6% endothelial cells.
“This method consistently yields cardiac organoids comprised of approximately 59% cardiomyocytes, 16% epicardial cells, 14% endocardial cells, 12% cardiac fibroblasts, and 1.6% endothelial cells”
Quote in the paperSubstantial claim - Findingown data
None of these phenotypes were found in NHOs.
“None of these phenotypes were found in NHOs.”
Quote in the paperSubstantial claim - Findingown data
NHOs and PGDHOs showed significant morphological differences as early as day 4 of differentiation.
“NHOs and PGDHOs showed significant morphological differences as early as day 4 of differentiation.”
Quote in the paperSubstantial claim - Findingown data
PGDHOs remained spherical throughout the two-week differentiation period.
“while PGDHOs remained spherical throughout the two-week period (Fig. 7a; Supplementary Fig. 8a).”
Quote in the paperSubstantial claim - Findingown data
hHOs present strong regular calcium waves typical of cardiac muscle, consistent with electrophysiology data.
“hHOs presented strong regular calcium waves typical of cardiac muscle and in agreement with our electrophysiology data (Fig. 6e, Supplementary Movie 11).”
Quote in the paperSubstantial claim - Findingown data
Immunofluorescence for MYL2 and MYL7 in day 15 hHOs showed cardiomyocytes positive for both subtypes.
“Immunofluorescence for MYL2 (encodes myosin light chain-2, ventricular subtype) and MYL7 (encodes myosin light-chain 7, atrial subtype) in day 15 hHOs showed cardiomyocytes positive for both subtypes.”
Quote in the paperSubstantial claim - Findingown data
hHOs treated with BMP4 and Activin A were about 15% larger in diameter than control hHOs.
“However, significant differences in organoid size were observed as hHOs treated with growth factors were about 15% larger in diameter”
Quote in the paperNot a substantial claim - Findingown data
BMP4/Activin A-treated hHOs had internal chamber-like cavities that were ~50% more interconnected with other chambers compared to control hHOs.
“This difference may correspond with increased chamber connectivity, as BMP4/Activin A-treated hHOs had internal chamber-like cavities that were ~50% more interconnected with other chambers compared to control hHOs”
Quote in the paperSubstantial claim - Findingown data
Expression of HAND1, HAND2, and MYL7 transcripts was observed throughout the differentiation protocol by RNA-seq and was similar to that observed in human fetal hearts.
“The expression of HAND1, HAND2, and MYL7 transcripts was also observed throughout the differentiation protocol by RNA-seq and was similar to that observed in human fetal hearts”
Quote in the paperSubstantial claim - Findingown data
Control hHOs show no significant programmed cell death (apoptosis) as indicated by FlipGFP.
“FlipGFP organoids in control conditions exhibited no fluorescence indicating that there is no significant programmed cell death (Supplementary Fig. 6e).”
Quote in the paperSubstantial claim - Findingown data
PGDHOs show irregular frequency of action potentials.
“Electrophysiological analysis showed irregular frequency of action potentials in PGDHOs suggesting arrhythmic events (Fig. 7c and Supplementary Fig. 8b, c).”
Quote in the paperSubstantial claim - Findingown data
hHOs show robust beating throughout the entire structure within a week from differentiation initiation and up to at least 8 weeks in culture.
“shows robust beating throughout the entire structure within a week from differentiation initiation and up to at least 8 weeks in culture (longer culture times were not attempted).”
Quote in the paperSubstantial claim - Findingown data
BMP4/ActA treatment significantly changed organoid diameter compared to control (p = 0.012).
“b organoid diameter, (n = 13 organoids per condition, value = mean ± s.d., two-tailed, unpaired t-test, *p = 0.012).”
Quote in the paperNot a substantial claim - Findingown data
PGDHOs were significantly larger after 1 week of differentiation.
“PGDHOs were also significantly larger after 1 week of differentiation (Fig. 7b)”
Quote in the paperSubstantial claim - Findingown data
Day 15 hHOs have clear chamber spaces observable by OCT.
“OCT showed clear chamber spaces within day 15 hHOs (Fig. 6a, Supplementary Fig. 6a–c).”
Quote in the paperSubstantial claim - Findingown data
hHOs have a high degree of interconnectivity between internal chambers.
“3D reconstruction of the internal hHO topology revealed a high degree of interconnectivity between these chambers (Supplementary Movies 7–10)”
Quote in the paperNot a substantial claim - Findingown data
PGDHOs had a significantly higher number of lipid droplets.
“TEM imaging revealed PGDHOs had a reduced number of mitochondria surrounding sarcomeres and a significantly higher number of lipid droplets”
Quote in the paperSubstantial claim - Findingown data
PGDHOs have increased glycolysis compared to cells dissociated from NHOs.
“Metabolic assays for glycolysis and oxygen consumption revealed decreased oxygen consumption rate in PGDHOs and increased glycolysis when compared to cells dissociated from NHOs (Fig. 7d, e, Supplementary Fig. 8d).”
Quote in the paperSubstantial claim - Findingown data
PGDHOs had a reduced number of mitochondria surrounding sarcomeres.
“TEM imaging revealed PGDHOs had a reduced number of mitochondria surrounding sarcomeres and a significantly higher number of lipid droplets”
Quote in the paperSubstantial claim - Findingown data
hHOs contain cells representing both heart fields.
“We found evidence of cells representing both heart fields in our organoids.”
Quote in the paperSubstantial claim - Findingown data
Diabetic conditions affect the developmental process of hHOs.
“Using healthy and diabetic levels of glucose and insulin in the differentiation media, we demonstrate the effects of diabetic conditions on the developmental process of hHOs.”
Quote in the paperSubstantial claim - Findingown data
hHOs have a complex transcriptome highly recapitulative of human fetal heart tissue.
“The depiction of a complex transcriptome highly recapitulative of human fetal heart tissue further strengthens the potential use of hHOs as models of human heart development.”
Quote in the paperSubstantial claim - Findingown data
hHOs formed vascular structures without additional steps.
“Remarkably, we observed the formation of vascular structures in our final protocol for hHOs without any additional steps.”
Quote in the paperSubstantial claim - Findingown data
hHOs contain cardiac fibroblast markers including THY1 and Vimentin.
“Immunofluorescence analysis of our hHOs revealed the presence of cardiac fibroblast markers including the membrane glycoprotein THY1, which is involved in cell-cell and cell-matrix adhesion73,74, and the intermediate filament protein Vimentin, typically seen in cells of mesenchymal lineage74.”
Quote in the paperSubstantial claim - Findingown data
The hHO protocol produces heart organoids with well-defined regions of epicardial tissue adjacent to myocardial tissue.
“we created and optimized conditions for producing heart organoids with well-defined regions of epicardial tissue adjacent to myocardial tissue.”
Quote in the paperSubstantial claim - Findingown data
hHOs express specific ECM genes resembling the fetal heart matrix, including COL1A1, COL4A1, COL5A2, FBN1, EMILIN1, HSPG2, and LAMA2.
“Expression of specific ECM genes in the hHOs resembling the fetal heart matrix, such as COL1A1, COL4A1, COL5A2, FBN1, EMILIN1, HSPG2, and LAMA2 (Supplementary Fig. 3d)”
Quote in the paperSubstantial claim - Findingown data
hHOs spontaneously reorganize into interconnected chambers, recapitulating fetal-like organogenesis.
“we also observed spontaneous hHO reorganization into interconnected chambers, a powerful 3D feature that recapitulates fetal-like organogenesis.”
Quote in the paperSubstantial claim - Findingown data
hHOs express cardiac fibroblast markers DDR2 and PDGFRα via RNA-sequencing.
“Other cardiac fibroblast markers were found in the hHOs via RNA-sequencing analysis, including DDR2 which plays an important role in EMT73, and the FHF marker PDGFRα, which is also crucial for vascularization during development74.”
Quote in the paperSubstantial claim - Findingown data
Cardiomyocytes from atrial and ventricular lineages are seen in separate regions in hHOs.
“as cardiomyocytes from both lineages are seen in separate regions in our hHOs.”
Quote in the paperSubstantial claim - Premisecitation
Tissue engineering approaches frequently do not faithfully represent the original cell composition and organization of the heart.
“Furthermore, they frequently do not faithfully represent the original cell composition (e.g., use of dermal fibroblasts or HUVECs)8,9 and organization (e.g., cardiospheres10,11) of the heart.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [8] Richards, D. J. et al. Inspiration from heart development: biomimetic development of functional human cardiac organoids. Biomaterials 142, 112–123 (2017). source
Not checked in the free run.
- cites [9] Richards, D. J. et al. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nat. Biomed. Eng. 4, 446–462 (2020). source
Not checked in the free run.
- cites [10] Fischer, B. et al. A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres. Stem Cell Res. 32, 65–72 (2018). source
Not checked in the free run.
- cites [11] Davis, D. R. et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS ONE 4, e7195 (2009). source
Not checked in the free run.
- Premisecitation
Progress on the creation of human heart organoid models for cardiovascular disease studies has been limited and lags significantly behind other organs.
“progress on the creation of human heart organoid models for cardiovascular disease studies has been limited and lags significantly behind other organs (e.g., kidney, colon, intestine, brain)1–4.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [1] Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564–568 (2015). source
Not checked in the free run.
- cites [2] Crespo, M. et al. Colonic organoids derived from human induced pluripotent stem cells for modeling colorectal cancer and drug testing. Nat. Med. 23, 878–884 (2017). source
Not checked in the free run.
- cites [3] Serra, D. et al. Self-organization and symmetry breaking in intestinal organoid development. Nature 569, 66–72 (2019). source
Not checked in the free run.
- cites [4] Mansour, A. A. et al. An in vivo model of functional and vascularized human brain organoids. Nat. Biotechnol. 36, 432–441 (2018). source
Not checked in the free run.
- Premisecitation
hPSCs enable recapitulation of important developmental steps in vitro to produce specific cardiac cell types with relative ease, high purity, and in large amounts.
“Human pluripotent stem cells (hPSCs) enable us to recapitulate important developmental steps in vitro to produce specific cardiac cell types with relative ease, high purity, and in large amounts5–7.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Dunn, K. K. & Palecek, S. P. Engineering scalable manufacturing of high-quality stem cell-derived cardiomyocytes for cardiac tissue repair. Front. Med. 5, 1–18 (2018). source
Not checked in the free run.
- cites [6] Burridge, P. W. et al. Chemically defned generation of human cardiomyocytes. Nat. Methods 11, 855–860 (2014). source
Not checked in the free run.
- cites [7] Kurian, L. et al. Identification of novel long noncoding RNAs underlying vertebrate cardiovascular development. Circulation 131, 1278–1290 (2015). source
Not checked in the free run.
- Interpretationcitation
Enhanced differentiation at lower CHIR concentrations can be attributed to endogenous morphogen production due to the self-assembling conditions.
“We believe enhanced differentiation at lower CHIR concentrations can be attributed to endogenous morphogen production due to the self-assembling conditions provided28–32.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [28] Witty, A. D. et al. Generation of the epicardial lineage from human pluripotent stem cells. Nat. Biotechnol. 32, 1026–1035 (2014). source
Not checked in the free run.
- cites [29] Burridge, P. W., Keller, G., Gold, J. D. & Wu, J. C. Production of de novo cardiomyocytes: Human pluripotent stem cell differentiation and direct reprogramming. Cell Stem Cell 10, 16–28 (2012). source
Not checked in the free run.
- cites [30] Protze, S. I., Lee, J. H. & Keller, G. M. Human pluripotent stem cell-derived cardiovascular cells: from developmental biology to therapeutic applications. Cell Stem Cell 25, 311–327 (2019). source
Not checked in the free run.
- cites [31] Jackson, S. A., Schiesser, J., Stanley, E. G. & Elefanty, A. G. Differentiating embryonic stem cells pass through ‘Temporal Windows’ that mark responsiveness to exogenous and paracrine mesendoderm inducing signals. PLoS ONE 5, e10706 (2010). source
Not checked in the free run.
- cites [32] Titmarsh, D. M. et al. Microbioreactor arrays for full factorial screening of exogenous and paracrine factors in human embryonic stem cell differentiation. PLoS ONE 7, e52405 (2012). source
Not checked in the free run.
- Interpretationown data
The second CHIR99021 exposure led to the formation of other mesenchymal lineages and higher complexity in hHOs due to induction of proepicardial organ formation.
“Results from the transcriptomic analysis (Fig. 2) suggested that the second CHIR99021 exposure led to the formation of other mesenchymal lineages and higher complexity in hHOs due to induction of proepicardial organ formation.”
Quote in the paperSubstantial claim - Interpretationown data
During hHO development, endothelial vascular structures emerge, adding a vascular network to the organoids.
“These results strongly indicate that during hHO development, endothelial vascular structures emerge, adding a vascular network to the organoids.”
Quote in the paperSubstantial claim - Study design and conductown data
Doxorubicin-treated hHOs showed evident signs of cell death, serving as a positive control for apoptosis.
“Doxorubicin-treated hHOs were used as a positive control for apoptosis (Supplementary Fig. 6e), with evident signs of cell death.”
Quote in the paperNot a substantial claim - Interpretationown data
The larger size of PGDHOs suggests macrosomia, a common outcome of newborns born to diabetic mothers.
“suggesting macrosomia, a common outcome of newborns born to diabetic mothers47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Schwartz, R. et al. Hyperinsulinemia and macrosomia in the fetus of the diabetic mother. Diabetes Care 17, 640–648 (1994). source
Not checked in the free run.
- Interpretationown data
The impairments in structural/developmental organization and lipid metabolism in PGDHOs are consistent with expected phenotypes found in PGD-induced CHD.
“These impairments in structural/developmental organization and lipid metabolism in PGDHOs are consistent with expected phenotypes found in PGD-induced CHD.”
Quote in the paperSubstantial claim - Interpretationown data
hHOs show ultrastructural features similar to early human fetal hearts, including well-defined sarcomeres surrounded by mitochondria, gap junctions, and T-tubule-like structures.
“Ultrastructural analysis of hHOs showed similar features to those found in early human fetal hearts, with well-defined sarcomeres surrounded by mitochondria, gap junctions and the presence of tubular structures reminiscent of T-tubules (Fig. 6b), also confirmed by immunofluorescence staining with WGA (Fig. 6c, Supplementary Fig. 6f).”
Quote in the paperSubstantial claim - Interpretationown data
The data suggest significant molecular and metabolic perturbations between NHOs and PGDHOs, consistent with previous studies on PGD suggesting increased oxidative stress, cardiomyopathy, and altered lipid profiles.
“Taken together, our data suggest significant molecular and metabolic perturbations between NHOs and PGDHOs consistent with previous studies on PGD suggesting increased oxidative stress, cardiomyopathy, and altered lipid profiles48–50”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [48] Moazzen, H. et al. N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes. Cardiovasc. Diabetol. 13, 1–13 (2014). source
Not checked in the free run.
- cites [49] Giacco, F. & Brownlee, M. Oxidative stress and diabetic complications. Circ. Res. 107, 1058–1070 (2010). source
Not checked in the free run.
- cites [50] Wu, Y. et al. Type 2 diabetes mellitus induces congenital heart defects in murine embryos by increasing oxidative stress, endoplasmic reticulum stress, and apoptosis. Am. J. Obstet. Gynecol. 215, 366.e1–366.e10 (2016). source
Not checked in the free run.
- Interpretationown data
PGDHOs exhibit arrhythmic events.
“Electrophysiological analysis showed irregular frequency of action potentials in PGDHOs suggesting arrhythmic events (Fig. 7c and Supplementary Fig. 8b, c).”
Quote in the paperSubstantial claim - Interpretationown data
The decreased ventricular and enlarged atrial regions in PGDHOs are indicative of structural defects such as those observed in CHD.
“indicative of structural defects such as those observed in CHD (Fig. 7g, Supplementary Fig. 8f).”
Quote in the paperSubstantial claim - Study design and conductnone given
hHO ability to recapitulate heart development is limited compared to other existing models such as mice.
“Second, their ability to recapitulate heart development is still limited when compared to other existing models, such as mice, even though they have the significant advantage of being human in origin rather than a surrogate animal model.”
Quote in the paperNot a substantial claim - Premisecitation
Cardiac fibroblasts facilitate cardiomyocyte functionality in hPSC-derived 3D cardiac microtissues.
“These fibroblasts facilitate cardiomyocyte functionality in hPSC-derived 3D cardiac microtissues, and as such, their inclusion in any in vitro human heart model is paramount61.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] Giacomelli, E. et al. Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease. Cell Stem Cell 26, 862–879.e11 (2020). source
Not checked in the free run.
- Interpretationown data
The larger size of diabetic hHOs suggests potential signs of cardiac hypertrophy, a hallmark of maternal PGD.
“The larger size of diabetic hHOs also suggests potential signs of cardiac hypertrophy, a hallmark of maternal PGD89.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] Gandhi, J. A., Zhang, X. Y. & Maidman, J. E. Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies. Am. J. Obstet. Gynecol. 173, 1132–1136 (1995). source
Not checked in the free run.
- Premisecitation
Most cardiac fibroblasts in embryonic development arise from the proepicardial organ (PEO).
“Most cardiac fibroblasts in embryonic development arise from the PEO36,72,73”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [36] Brade, T., Pane, L. S., Moretti, A., Chien, K. R. & Laugwitz, K. L. Embryonic heart progenitors and cardiogenesis. Cold Spring Harb. Perspect. Med. 3, 1–18 (2013). source
Not checked in the free run.
- cites [72] Lajiness, J. D. & Conway, S. J. Origin, development, and differentiation of cardiac fibroblasts. J. Mol. Cell. Cardiol. 70, 2–8 (2014). source
Not checked in the free run.
- cites [73] Doppler, S. A. et al. Cardiac fibroblasts: more than mechanical support. J. Thorac. Dis. 9, S36–S51 (2017). source
Not checked in the free run.
- Interpretationown data
hHOs can be used to model features of pregestational diabetes-induced congenital heart disease.
“We provide evidence that heart organoids can be valuable models to study CHD in pregestational diabetes-like conditions.”
- Also stated in: § Discussion · hedged
“These data suggest hHOs might be useful tools for the study of PGD-induced CHD”
- Also stated in: § Discussion · plain
“Heart organoids can be used to model features of pregestational diabetes-induced congenital heart disease”
Quote in the paperSubstantial claim - Also stated in: § Discussion · hedged
- Study design and conductnone given
Immunofluorescence and bulk RNA sequencing may not fully capture the heterogeneity of hHOs.
“It should be noted that while our immunofluorescence and bulk RNA sequencing data suggest the presence of the cardiac cell types described above, these techniques may not fully capture the heterogeneity of our organoids.”
Quote in the paperNot a substantial claim
- May combine two claims. 48
- Classified as probably not a substantial claim. 22
May combine two claims.
Findingown datahHOs developed sarcomeres as early as day 7, with clearer sarcomere banding and fiber assembly by day 15.
“Confocal microscopy for the cardiomyocyte-specific marker TNNT2 showed that organoids developed sarcomeres as early as day 7 (Fig. 1b), with much clearer sarcomere banding and fiber assembly by day 15”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBeating hHOs appeared as early as day 6, with robust and regular beating by day 10 in all organoids and lasting for at least 8 weeks in culture.
“Beating hHOs appeared as early as day 6 of the differentiation protocol, with robust and regular beating by day 10 in all organoids and lasting for at least 8 weeks in culture”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOptimal conditions for the first Wnt activation were critical for successful heart organoid formation and differed from those reported for cardiac lineage monolayer differentiation.
“We found out that optimal conditions for the first Wnt activation were critical for successful heart organoid formation and differed from those reported for cardiac lineage monolayer differentiation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataHigh concentrations or long exposure times of CHIR99021 at the second Wnt activation inhibited cardiac cell type formation and provoked extensive epicardial expansion.
“however, high concentrations or long exposure times inhibited cardiac cell type formation and provoked an undesired extensive epicardial expansion”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe hHO cell composition is 12.49 ± 1.01% cardiac fibroblasts, 13.82 ± 1.54% endocardial cells, and 1.63 ± 0.21% endothelial cells.
“Figure 3f shows a quantification of the contribution of the different cardiac cell populations to the organoids, with a composition of 12.49 ± 1.01% cardiac fibroblasts, 13.82 ± 1.54% endocardial cells, and 1.63 ± 0.21% endothelial cells.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahHOs recapitulate heart field formation and atrioventricular specification.
“recapitulate heart field formation and atrioventricular specification”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataImaging revealed a robust interconnected network of endothelial cells (PECAM1+) and vessel-like tube formation throughout the organoid assembling between day 11 and 13.
“Further imaging revealed a robust interconnected network of endothelial cells (PECAM1 + ), and vessel-like tube formation throughout the organoid assembling between day 11 and 13”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataImmunofluorescence of day 7 hHO cryosections showed well-differentiated regions of HAND1 and HAND2 cells in the same organoid, suggesting both FHF and SHF progenitors are present and segregated into their respective heart fields.
“Immunofluorescence of day 7 hHO cryosections showed well-differentiated regions of HAND1 and HAND2 (Fig. 4a) cells in the same organoid, suggesting that both FHF and SHF progenitors are present and segregated into their respective heart fields.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataNHOs were slower to grow and exhibited patterning and elongation between days 4 and 8.
“NHOs were slower to grow and exhibited patterning and elongation between days 4 and 8”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAtrial cardiomyocytes made up most of the cell population (~48%) while ventricular cardiomyocytes made up about one fifth (~18%) of the total cells in the organoids at day 15.
“Atrial cardiomyocytes made up most of the cell population (~48%) while ventricular cardiomyocytes made up about one fifth (~18%) of the total cells in the organoids at day 15”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataBMP4/ActA treatment did not significantly change the percentage of cardiomyocyte (TNNT2+) or epicardial (WT1+TJP1+) positive cells relative to control.
“a Percent of cardiomyocyte and epicardial positive cells as a percentage of total DAPI + nuclei (n = 7 organoids per condition, value = mean ± s.d., 2-way ANOVA Sidak’s multiple comparisons test, ns: p = 0.76 for TNNT2 and p = 0.97 for WT1 + TJP1)”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataBMP4 and Activin A treatment caused a 160% increase in PECAM1+ cells, indicating a significant effect on organoid vascularization.
“Notably, immunofluorescence analysis of organoids treated with BMP4 and Activin A showed a 160% increase in PECAM1+ cells too, indicating a significant effect on organoid vascularization”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahHOs contain 4-6 chambers near the center, with volumes ranging from 5.5e−4 mm3 to 1.3e−2 mm3.
“revealing 4–6 chambers near the center of the organoid ranging from 5.5e−4 mm3 to 1.3e−2 mm3 (Supplementary Fig. 6d, Supplementary Movie 10).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown datahHOs exhibit robust beating and normal electrophysiological activity with action potential waves reminiscent of QRS, T, and P waves and regular action potentials.
“we could detect robust beating and normal electrophysiological activity with well-defined action potential waves reminiscent of QRS complexes, T and P waves, and regular action potentials across multiple organoids (Fig. 6d).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe two different populations localized to different regions of the organoid and were in close proximity, mirroring the expression pattern seen in human hearts.
“The two different populations localized to different regions of the organoid and were in close proximity, which mirrors the expression pattern seen in human hearts”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataSHF markers appeared later, only becoming prominent around day 7, and expressing throughout the organoid up to day 9.
“SHF markers appeared later in the process, only becoming prominent around day 7, and expressing throughout the organoid up to day 9”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPGDHOs contained epicardial tissue surrounded by myocardial tissue, whereas NHOs contained epicardial tissue on top of or beside myocardial tissue.
“PGDHOs contained epicardial tissue surrounded by myocardial tissue, whereas NHOs contained epicardial tissue on top of or beside myocardial tissue as physiologically expected (Fig. 7h).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDiabetic hHOs showed decreased MYL2+ ventricular cardiomyocytes and enlarged MYL7+ atrial cardiomyocyte regions compared with normal glycemia.
“Compared with normal glycemia conditions, diabetic hHOs showed decreased MYL2 + ventricular cardiomyocytes and enlarged MYL7 + atrial cardiomyocyte regions”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTreatment with BMP4 and Activin A in addition to CHIR increased PECAM1+ cells by 160% relative to control, indicating a significant effect on organoid vascularization.
“with BMP4 and Activin A showed a 160% increase in PECAM1+ cells too, indicating a significant effect on organoid vascularization (Fig. 5f, g).”
- Also stated in: § BMP4 and Activin A improve heart organoid chamber formation and vascularization · plain
“f PECAM1 + cells as a percentage of total DAPI + nuclei, (n = 7 organoids per condition, value = mean ± s.d., two-tailed, unpaired t-test, **p = 0.0023).”
Quote in the paperSubstantial claim- Also stated in: § BMP4 and Activin A improve heart organoid chamber formation and vascularization · plain
May combine two claims.
Findingown dataFHF markers were observed as early as day 3 (prior to TNNT2 detection), confined to specific regions on the organoid, and reducing in expression around day 9.
“FHF markers were observed as early as day 3 (prior to TNNT2 detection), confined to specific regions on the organoid, and reducing in expression around day 9”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared with existing cardiomyocyte monolayer differentiation methods, hHOs showed higher expression of genes associated with conduction, contractile function, calcium handling, and various cardiac cell populations, which better resemble gene expression data from human fetal hearts.
“When compared with existing cardiomyocyte monolayer differentiation methods, hHOs showed higher expression of genes associated with conduction, contractile function, calcium handling, and various cardiac cell populations, which better resemble gene expression data retrieved from human fetal hearts.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown datahHOs form multiple chambers lined with NFATC1+ endocardial cells that are interconnected.
“The hHOs reported here form multiple chambers lined with NFATC1+ endocardial cells which are interconnected as seen in the OCT cross-sectional imaging (Supplementary Movies 7–10).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationHybrid cardiac-foregut organoids from human PSCs have been reported with external heart layers and an internal endodermal core.
“Hybrid cardiac-foregut organoids from human PSCs have also been reported very recently, with external heart layers and an internal endodermal core19”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Drakhlis, L. et al. Human heart-forming organoids recapitulate early heart and foregut development. Nat. Biotechnol. 39, 737–746 (2021). source
Not checked in the free run.
May combine two claims.
PremisecitationThese cardioids relied heavily on complex growth factor mixtures, co-culture approaches to include epicardial clusters, and independent differentiation protocols.
“While demonstrating a large leap in self-assembling capabilities, these cardioids still relied heavily on complex growth factor mixtures, co-culture approaches to include epicardial clusters, and independent differentiation protocols to achieve their final results.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [19] Drakhlis, L. et al. Human heart-forming organoids recapitulate early heart and foregut development. Nat. Biotechnol. 39, 737–746 (2021). source
Not checked in the free run.
- cites [20] Hofbauer, P. et al. Cardioids reveal self-organizing principles of human cardiogenesis. Cell. 184, 3299–3317 (2021). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe hHO method is automatable, scalable, and amenable to high-content/high-throughput pharmacological screenings.
“It is also automatable, scalable, and amenable to high-content/high-throughput pharmacological screenings.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationMouse ESCs have been used to generate precardiac organoids showing distinct heart field specifications, cardiac crescent-like structures juxtaposed with primitive gut tube, and atrial and ventricular cardiomyocyte lineages.
“Recently, mouse embryonic stem cells (ESCs) were used to generate precardiac organoids showing distinct heart field specifications16, cardiac crescent-like structures juxtaposed with primitive gut tube17, and atrial and ventricular cardiomyocyte lineages18.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [16] Andersen, P. et al. Precardiac organoids form two heart fields via Bmp/Wnt signaling. Nat. Commun. 9, 1–13 (2018). source
Not checked in the free run.
- cites [17] Rossi, G. et al. Capturing cardiogenesis in gastruloids. Cell Stem Cell 28, 230–240 (2020). source
Not checked in the free run.
- cites [18] Lee, J. et al. In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix. Nat. Commun. 11, 1–18 (2020). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationCardioids have been reported with a large internal chamber, relevant cardiac cell lineages and single cell transcriptomic analysis.
“cardioids (an alternative nomenclature for heart or cardiac organoids) have been reported with a large internal chamber, relevant cardiac cell lineages and single cell transcriptomic analysis20.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [20] Hofbauer, P. et al. Cardioids reveal self-organizing principles of human cardiogenesis. Cell. 184, 3299–3317 (2021). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based). May combine two claims.
Interpretationnone givenThe hHO method is low-cost compared to growth factor-based approaches and involves less steps and manipulation than currently existing methods.
“Our method is low-cost when compared to growth factor-based approaches and involves less steps and manipulation than currently existing methods.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationTissue engineering approaches for heart-on-a-chip or heart organoid models allow high control of the end construct but tend to be expensive, work-intensive, and not readily scalable.
“While these approaches allow for high control of the end construct, they tend to be expensive, work-intensive, and not readily scalable.”
Quote in the paperSubstantial claim0 of 8 sources checked- cites [8] Richards, D. J. et al. Inspiration from heart development: biomimetic development of functional human cardiac organoids. Biomaterials 142, 112–123 (2017). source
Not checked in the free run.
- cites [9] Richards, D. J. et al. Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity. Nat. Biomed. Eng. 4, 446–462 (2020). source
Not checked in the free run.
- cites [10] Fischer, B. et al. A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres. Stem Cell Res. 32, 65–72 (2018). source
Not checked in the free run.
- cites [11] Davis, D. R. et al. Validation of the cardiosphere method to culture cardiac progenitor cells from myocardial tissue. PLoS ONE 4, e7195 (2009). source
Not checked in the free run.
- cites [12] Ronaldson-Bouchard, K. et al. Advanced maturation of human cardiac tissue grown from pluripotent stem cells. Nature 556, 239–243 (2018). source
Not checked in the free run.
- cites [13] Li, Q. et al. Cyborg organoids: implantation of nanoelectronics via organogenesis for tissue-wide electrophysiology. Nano Lett. 19, 5781–5789 (2019). source
Not checked in the free run.
- cites [14] Mills, R. J. et al. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest. Proc. Natl Acad. Sci. USA 114, E8372–E8381 (2017). source
Not checked in the free run.
- cites [15] Ma, Z. et al. Self-organizing human cardiac microchambers mediated by geometric confinement. Nat. Commun. 6, 1–10 (2015). source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe hHO model has endocardial lined chambers within myocardial tissue, interspersed with cardiac fibroblasts and a network of endothelial cells, and complete with external epicardial tissue, features highly recapitulative of the developing human heart.
“Together, these observations depict a complex and sophisticated human heart organoid model with endocardial lined chambers within myocardial tissue, interspersed with cardiac fibroblasts and a network of endothelial cells, and complete with external epicardial tissue, features that are highly recapitulative of the developing human heart”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown datahHOs have significant enrichment in structural and cellular complexity, bringing them in line with fetal hearts and further away from monolayer-based differentiation.
“These data suggest a significant enrichment in the structural and cellular complexity of our hHOs, thus bringing them in line with fetal hearts and further away from monolayer-based differentiation.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationFHF and SHF are two cell populations found in the developing heart.
“The first and second heart fields (FHF, SHF) are two cell populations found in the developing heart.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Brade, T., Pane, L. S., Moretti, A., Chien, K. R. & Laugwitz, K. L. Embryonic heart progenitors and cardiogenesis. Cold Spring Harb. Perspect. Med. 3, 1–18 (2013). source
Not checked in the free run.
May combine two claims.
Interpretationown datahHO expression profiles are similar to those of fetal hearts, and their global transcriptomes are closer to those of fetal hearts than monolayer protocols.
“Taken together, these data suggest hHO expression profiles are similar to those of fetal hearts, and their global transcriptomes are closer to those of fetal hearts than monolayer protocols, as determined by hierarchical clustering”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe organoid platform can recreate complex metabolic disorders associated with congenital heart defects, as demonstrated by an in vitro model of pregestational diabetes-induced congenital heart defects.
“We also show that our organoid platform can recreate complex metabolic disorders associated with congenital heart defects, as demonstrated by an in vitro model of pregestational diabetes-induced congenital heart defects.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataThe resulting hHOs contained significant myocardial tissue with epicardial tissue clustered near the outer surface of the organoids, mimicking the anatomical structure of the developing embryonic heart.
“Overall, the resulting hHOs contained significant myocardial tissue with epicardial tissue clustered near the outer surface of the organoids, mimicking the anatomical structure of the developing embryonic heart”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductown dataThe hHO differentiation protocol was reproducible across multiple hPSC lines (iPSC-L1, AICS-37-TNNI1-mEGFP, iPSCORE_16_3, H9), all of which exhibited similar differentiation efficiencies, beat metrics, growth rates, and sizes.
“Our hHO differentiation protocol was reproducible across multiple hPSC lines (iPSC-L1, AICS-37-TNNI1-mEGFP, iPSCORE_16_3, H9), all of which exhibited similar differentiation efficiencies, beat metrics, growth rates, and sizes”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataBMP4/ActA treatment improves morphological and structural organization in developing hHOs, including increased chamber interconnectivity and vascularization.
“These results suggest improved structural organization in the developing organoids under BMP4/ActA, in agreement with previously reported differentiation methods using BMP4 and Activin A alone16.”
- Also stated in: § Discussion · plain
“The addition of these growth factors to the initial CHIR exposure in our hHO differentiation protocol led to improved morphological features, such as increased chamber interconnectivity and vascularization.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Andersen, P. et al. Precardiac organoids form two heart fields via Bmp/Wnt signaling. Nat. Commun. 9, 1–13 (2018). source
Not checked in the free run.
- Also stated in: § Discussion · plain
May combine two claims.
Study design and conductown datahHOs were successfully derived from four independent iPSC lines and one ESC line, demonstrating reproducibility.
“Notably, hHOs were successfully derived from four independent iPSC lines and one ESC line, demonstrating reproducibility.”
Quote in the paperSubstantial claimMay combine two claims.
Interpretationown dataPGDHOs show dysfunctional lipid metabolism and a more glycolytic profile.
“suggesting dysfunctional lipid metabolism and a more glycolytic profile (Fig. 7f, Supplementary Fig. 8e).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn human hearts, the left ventricle ultimately forms from FHF progenitors, and the atria form from SHF progenitors.
“In human hearts, the left ventricle ultimately forms from FHF progenitors, and the atria form from SHF progenitors38.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [38] Kelly, R. G., Buckingham, M. E. & Moorman, A. F. Heart fields and cardiac morphogenesis. Cold Spring Harb. Perspect. Med. 4, 1–11 (2014). source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationCells from the FHF contribute to linear heart tube formation, followed by migrating SHF cells that contribute to further expansion and chamber formation.
“Cells from the FHF contribute to the linear heart tube formation, followed by migrating cells belonging to the SHF that contribute to further expansion and chamber formation36.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36] Brade, T., Pane, L. S., Moretti, A., Chien, K. R. & Laugwitz, K. L. Embryonic heart progenitors and cardiogenesis. Cold Spring Harb. Perspect. Med. 3, 1–18 (2013). source
Not checked in the free run.
May combine two claims.
Interpretationown datahHOs contain most cardiac lineages and have multicell type and morphological complexity reminiscent of the developing human fetal heart, including chamber formation, atrioventricular specification, electrophysiological activity, and vascularization.
“These conditions lead to the formation of most cardiac lineages in a self-assembling heart organoid with similar properties to the fetal heart.”
- Also stated in: § Discussion · plain
“Heart organoids present multicell type and morphological complexity reminiscent of the developing human fetal heart, including chamber formation, atrioventricular specification, electrophysiological activity and vascularization.”
- Also stated in: § Discussion · hedged
“These data provide a strong indication of the increased complexity of our hHO system and its close resemblance to fetal heart tissue.”
Quote in the paperSubstantial claim- Also stated in: § Discussion · plain
Classified as probably not a substantial claim. May combine two claims.
PremisecitationHAND1 and HAND2 are members of the Twist family of bHLH transcription factors that play key roles in the developing heart.
“HAND1 (FHF) and HAND2 (SHF) are members of the Twist family of basic helix-loop-helix (bHLH) transcription factors that play key roles in the developing heart37.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [37] George, R. M. & Firulli, A. B. Hand factors in cardiac development. Anat. Rec. 302, 101–107 (2019). source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe differentiation of hHOs involves heart field formation, atrioventricular specification and chamber formation, further emphasizing their recapitulation of human cardiac development.
“Taken together, these data suggest that the differentiation of our hHOs involves heart field formation, atrioventricular specification and chamber formation, all of which further emphasizes their recapitulation of human cardiac development.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBMP4 and Activin A are endogenous morphogens that pattern the early embryonic cardiogenic mesoderm and determine heart field specification in vivo.
“The growth factors bone morphogenetic protein 4 (BMP4) and Activin A have frequently been used as alternatives to small molecule-mediated Wnt signaling manipulation, since they are the endogenous morphogens that pattern the early embryonic cardiogenic mesoderm and determine heart field specification in vivo16,39–41.”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [16] Andersen, P. et al. Precardiac organoids form two heart fields via Bmp/Wnt signaling. Nat. Commun. 9, 1–13 (2018). source
Not checked in the free run.
- cites [39] Sa, S. & McCloskey, K. E. Activin A and BMP4 signaling for efficient cardiac differentiation of H7 and H9 human embryonic stem cells. J. Stem Cells Regen. Med. 8, 198–202 (2012). source
Not checked in the free run.
- cites [40] Kattman, S. J. et al. Stage-specific optimization of activin/nodal and BMP signaling promotes cardiac differentiation of mouse and human pluripotent stem cell lines. Cell Stem Cell 8, 228–240 (2011). source
Not checked in the free run.
- cites [41] Elliott, D. A. et al. NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes. Nat. Methods 8, 1037–1040 (2011). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationBMP4 and Activin A induce cardiac mesoderm in the embryo, and established differentiation protocols using them differentiate to various cardiac mesoderm progenitors.
“These growth factors lead to the induction of cardiac mesoderm in the embryo70 and established differentiation protocols using them show effective differentiation to various cardiac mesoderm progenitors23,70,71.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [70] Später, D., Hansson, E. M., Zangi, L. & Chien, K. R. How to make a cardiomyocyte. Dev 141, 4418–4431 (2014). source
Not checked in the free run.
- cites [23] Breckwoldt, K. et al. Differentiation of cardiomyocytes and generation of human engineered heart tissue. Nat. Protoc. 12, 1177–1197 (2017). source
Not checked in the free run.
- cites [71] Kim, M. et al. Activin-A and Bmp4 levels modulate cell type specification during CHIR-induced cardiomyogenesis. PLoS ONE. 10, 1–16 (2015). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenOnly samples with over 90% viability were used in the Seahorse assay.
“Only samples with over 90% viability were used in the assay.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Study design and conductnone givenAll PSC lines used were validated for pluripotency and genomic stability.
“All PSC lines were validated for pluripotency and genomic stability.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenIdentical numbers of cells were plated for the Seahorse assay.
“Identical numbers of cells were plated for the assay.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductnone givenThe paper describes a highly reproducible and high-throughput human heart organoid generation method relying on self-assembly triggered by developmental cues and provides proof-of-concept for modeling a congenital heart disorder.
“In summary, we describe here a highly reproducible and high-throughput human heart organoid generation method relying on self-assembly triggered by developmental cues and provide proof-of-concept for the modeling of a congenital heart disorder.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMaternal diabetes is one of the most common causes of newborn CHD, with up to 12% of newborns from diabetic mothers having some form of CHD.
“Maternal diabetes is one of the most common causes of newborn CHD (up to 12% of newborns from diabetic mothers have some form of CHD88).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [88] Narchi, H. & Kulaylat, N. Heart disease in infants of diabetic mothers. Images Paediatr. Cardiol. 2, 17–23 (2000).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Study design and conductnone givenhHOs tend to deviate from their normal developmental pathway as a function of time, becoming less relevant the longer they are cultured.
“First, organoids tend to deviate from their normal developmental pathway as a function of time, becoming less relevant the longer they are cultured.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe axial resolution of the SD-OCT system was measured to be ~7 mm in tissue.
“The axial resolution of the SD-OCT system was measured to be ~7 mm in tissue.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenAll data represent a minimum of 3 independent experiments with at least 3 technical replicates unless otherwise stated.
“All data are presented as mean ± s.d. and represent a minimum of 3 independent experiments with at least 3 technical replicates unless otherwise stated.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenCalcium transient graphs are representative of 6 independent experiments.
“All micrograph images are representative of at least 6 independent experiments per condition/marker and calcium transient graphs are representative of 6 independent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenA 5X objective lens was used to achieve a transverse image resolution of ~7 mm.
“A 5X objective lens (5X Plan Apo NIR, Mitutoyo) was used to achieve a transverse image resolution of ~7 mm”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenAll micrograph images are representative of at least 6 independent experiments per condition/marker.
“All micrograph images are representative of at least 6 independent experiments per condition/marker and calcium transient graphs are representative of 6 independent experiments.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataThe sensitivity of the OCT system was measured as ~104 dB when operating at a 20 kHz A-scan rate.
“The sensitivity of the OCT system was measured as ~104 dB when operating at a 20 kHz A-scan rate.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationBMP4 and Activin A have been used successfully for cardiomyocyte differentiation.
“successful cardiomyocyte differentiation has been achieved in the past using morphogens such as BMP4 and Activin A21,26.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [21] Lian, X. et al. Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions. Nat. Protoc. 8, 162–175 (2013). source
Not checked in the free run.
- cites [26] Lian, X. et al. Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling. Proc. Natl. Acad. Sci. USA 109, 1–10 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationEpicardial-myocardial interactions are important in mammalian heart development and function; epicardial cells increase cardiomyocyte growth in 3D engineered heart tissues, and co-transplantation of both cell types into rat hearts increases endothelial cell production.
“These epicardial-myocardial interactions are important in mammalian heart development and function, as epicardial cells increase cardiomyocyte growth in 3D engineered heart tissues, and co-transplantation of both cell types into rat hearts increases endothelial cell production63.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [63] Bargehr, J. et al. Epicardial cells derived from human embryonic stem cells augment cardiomyocyte-driven heart regeneration. Nat. Biotechnol. 37, 895–906 (2019). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationGradient exposures to specific concentrations of BMP4 and Activin A have been studied in specification of first and second heart field formation.
“Recently, gradient exposures to specific concentrations of BMP4 and Activin A have been studied in the specification of first and second heart field formation16.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [16] Andersen, P. et al. Precardiac organoids form two heart fields via Bmp/Wnt signaling. Nat. Commun. 9, 1–13 (2018). source
Not checked in the free run.
The paper relies on this without support.
Current cell models are still far from the structural and cellular complexity of the tissues and organs they intend to represent.
“However, current cell models are still far away from the structural and cellular complexity of the tissues and organs they intend to represent (e.g., lack of 3D matrix, disorganized cells, and absence of multicell-type interactions).”
The paper relies on this without support.
The developmental stage of hHOs at day 19 is age-matched to human fetal hearts at gestational days 57–67.
“Heart organoids are comparable to age-matched human fetal cardiac tissues”
“human fetal heart tissue (gestational age days 57–67)33”
The paper relies on this without support.
Pregestational diabetes is associated with a substantially increased risk of congenital heart disease in the first trimester, and the underlying mechanisms are poorly understood in humans.
“Diabetes affects a large sector of the female population in reproductive age and comes associated with significant epidemiological evidence linking it to CHD during the first trimester of pregnancy (up to 12-fold risk increase, 12% vs. 1% risk for healthy females), but little understanding of the underlying mechanisms exists, especially in humans.”
The paper relies on this without support.
All data presented a normal distribution.
“All data presented a normal distribution.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Self-assembling human cardiac organoids have been used to show the role of BMP4 and Activin A to improve heart organoid chamber formation and vascularization.
“Self-assembling human cardiac organoids have also been used to show the role of BMP4 and Activin A to improve heart organoid chamber formation and vascularization [60].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [60]
Models of cardiovascular disease lag behind other organ models, often failing to mimic pulsatile flow and thus lacking a fundamental characteristic of human cardiac function.
“However, models of cardiovascular disease lag behind other organ models,[ 9 ] often failing to mimic pulsatile flow and thus lacking a fundamental characteristic of human cardiac function.[ 13 , 14 ]”
From Engineered in vitro multi-cell type ventricle model generates long-term pulsatile flow and modulates cardiac output in response to cardioactive drugs (2025) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
HAND1/HAND2 cryosections are dated day 7 and day 8
MinorThe results describe the cryosections as day 7, while the caption for the cited panel identifies them as day 8.
“Immunofluorescence of day 7 hHO cryosections showed well-differentiated regions of HAND1 and HAND2 (Fig. 4a) cells in the same organoid”
“a Confocal immunofluorescent images of two representative hHO cryosections on day 8 of differentiation”
Diabetes-results text cites the epicardial panel for atrial and ventricular cells
MinorThe text cites Fig. 7g for MYL2-positive ventricular and MYL7-positive atrial regions, but the caption says panel g shows TNNT2 and WT1 cardiac and epicardial staining. The caption assigns MYL2 and MYL7 to panel h.
“Compared with normal glycemia conditions, diabetic hHOs showed decreased MYL2 + ventricular cardiomyocytes and enlarged MYL7 + atrial cardiomyocyte regions, indicative of structural defects such as those observed in CHD (Fig. 7g, Supplementary Fig. 8f).”
“g Confocal immunofluorescence images at differentiation day 15 for cardiac (TNNT2, red) and epicardial (WT1, green) formation, scale bar: 500 µm. h Confocal imaging for ventricular (MYL2, green) and atrial (MYL7, red) chamber formation under normal and diabetic-like conditions, scale bar: 500 µm.”
Diabetes-results text cites the atrial/ventricular panel for epicardial tissue
MinorThe text cites Fig. 7h for myocardial and epicardial organization, but the caption says panel h shows ventricular and atrial staining; it assigns cardiac and epicardial staining to panel g.
“Immunofluorescence for myocardial and epicardial markers revealed a drastic difference in the morphological organization as PGDHOs contained epicardial tissue surrounded by myocardial tissue, whereas NHOs contained epicardial tissue on top of or beside myocardial tissue as physiologically expected (Fig. 7h).”
“g Confocal immunofluorescence images at differentiation day 15 for cardiac (TNNT2, red) and epicardial (WT1, green) formation, scale bar: 500 µm. h Confocal imaging for ventricular (MYL2, green) and atrial (MYL7, red) chamber formation under normal and diabetic-like conditions, scale bar: 500 µm.”
Cites
Ultrasensitive fluorescent proteins for imaging neuronal activity
Chen, T.-W., Wardill, T. J., Sun, Y., Pulver, S. R., Renninger, S. L., Baohan, A., Schreiter, E. R., Kerr, R. A., Orger, M. B., Jayaraman, V., et al. (2013) · Nature · doi:10.1038/nature12354 · Cited by 6,474 · see citing works
Oxidative stress and diabetic complications
Giacco, F., & Brownlee, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.223545 · Cited by 5,461 · see citing works
Diagnosis and classification of diabetes mellitus
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s062 · Cited by 1,817 · see citing works
Lian, X., Zhang, J., Azarin, S. M., Zhu, K., Hazeltine, L. B., Bao, X., Hsiao, C., Kamp, T. J., & Palecek, S. P. (2013) · Nature Protocols · doi:10.1038/nprot.2012.150 · Cited by 1,748 · see citing works
Lian, X., Hsiao, C., Wilson, G., Zhu, K., Hazeltine, L. B., Azarin, S. M., Raval, K. K., Zhang, J., Kamp, T. J., & Palecek, S. P. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200250109 · Cited by 1,717 · see citing works
Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis
Takasato, M., Er, P. X., Chiu, H. S., Maier, B., Baillie, G. J., Ferguson, C., Parton, R. G., Wolvetang, E. J., Roost, M. S., Chuva de Sousa Lopes, S. M., et al. (2015) · Nature · doi:10.1038/nature15695 · Cited by 1,627 · see citing works
Chemically defined generation of human cardiomyocytes
Burridge, P. W., Matsa, E., Shukla, P., Lin, Z. C., Churko, J. M., Ebert, A. D., Lan, F., Diecke, S., Huber, B., Mordwinkin, N. M., et al. (2014) · Nature Methods · doi:10.1038/nmeth.2999 · Cited by 1,606 · see citing works
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · see citing works
Advanced maturation of human cardiac tissue grown from pluripotent stem cells
Ronaldson-Bouchard, K., Ma, S. P., Yeager, K., Chen, T., Song, L., Sirabella, D., Morikawa, K., Teles, D., Yazawa, M., & Vunjak-Novakovic, G. (2018) · Nature · doi:10.1038/s41586-018-0016-3 · Cited by 1,272 · see citing works
An in vivo model of functional and vascularized human brain organoids
Mansour, A. A., Gonçalves, J. T., Bloyd, C. W., Li, H., Fernandes, S., Quang, D., Johnston, S., Parylak, S. L., Jin, X., & Gage, F. H. (2018) · Nature Biotechnology · doi:10.1038/nbt.4127 · Cited by 1,211 · see citing works
Kattman, S. J., Witty, A. D., Gagliardi, M., Dubois, N. C., Niapour, M., Hotta, A., Ellis, J., & Keller, G. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.12.008 · Cited by 1,159 · see citing works
Flow-enhanced vascularization and maturation of kidney organoids in vitro
Homan, K. A., Gupta, N., Kroll, K. T., Kolesky, D. B., Skylar-Scott, M., Miyoshi, T., Mau, D., Valerius, M. T., Ferrante, T., Bonventre, J. V., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0325-y · Cited by 939 · see citing works
Human blood vessel organoids as a model of diabetic vasculopathy
Wimmer, R. A., Leopoldi, A., Aichinger, M., Wick, N., Hantusch, B., Novatchkova, M., Taubenschmid, J., Hämmerle, M., Esk, C., Bagley, J. A., et al. (2019) · Nature · doi:10.1038/s41586-018-0858-8 · Cited by 803 · see citing works
A myocardial lineage derives from Tbx18 epicardial cells
Cai, C., Martin, J., Sun, Y., Cui, L., Wang, L., Ouyang, K., Yang, L., Bu, L., Liang, X., Zhang, X., et al. (2008) · Nature · doi:10.1038/nature06969 · Cited by 783 · see citing works
Burridge, P. W., Li, Y. F., Matsa, E., Wu, H., Ong, S., Sharma, A., Holmström, A., Chang, A. C. Y., Coronado, M. J., Ebert, A., et al. (2016) · Nature Medicine · doi:10.1038/nm.4087 · Cited by 746 · see citing works
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696 · see citing works
Burridge, P. W., Keller, G., Gold, J. D., & Wu, J. C. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2011.12.013 · Cited by 670 · see citing works
Growth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666 · see citing works
Giacomelli, E., Meraviglia, V., Campostrini, G., Cochrane, A., Cao, X., van Helden, R. W. J., Krotenberg Garcia, A., Mircea, M., Kostidis, S., Davis, R. P., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.05.004 · Cited by 622 · see citing works
Cardioids reveal self-organizing principles of human cardiogenesis
Hofbauer, P., Jahnel, S. M., Papai, N., Giesshammer, M., Deyett, A., Schmidt, C., Penc, M., Tavernini, K., Grdseloff, N., Meledeth, C., et al. (2021) · Cell · doi:10.1016/j.cell.2021.04.034 · Cited by 588 · see citing works
Self-organization and symmetry breaking in intestinal organoid development
Serra, D., Mayr, U., Boni, A., Lukonin, I., Rempfler, M., Challet Meylan, L., Stadler, M. B., Strnad, P., Papasaikas, P., Vischi, D., et al. (2019) · Nature · doi:10.1038/s41586-019-1146-y · Cited by 561 · see citing works
Liang, P., Lan, F., Lee, A. S., Gong, T., Sánchez-Freire, V., Wang, Y., Diecke, S., Sallam, K., Knowles, J. W., Wang, P. J., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.001883 · Cited by 535 · see citing works
High-resolution 3D imaging of fixed and cleared organoids
Dekkers, J. F., Alieva, M., Wellens, L. M., Ariese, H. C., Jamieson, P. R., Vonk, A. M., Amatngalim, G. D., Hu, H., Oost, K. C., Snippert, H. J. G., et al. (2019) · Nature Protocols · doi:10.1038/s41596-019-0160-8 · Cited by 534 · see citing works
Mills, R. J., Titmarsh, D. M., Koenig, X., Parker, B. L., Ryall, J. G., Quaife-Ryan, G. A., Voges, H. K., Hodson, M. P., Ferguson, C., Drowley, L., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707316114 · Cited by 478 · see citing works
Human heart-forming organoids recapitulate early heart and foregut development
Drakhlis, L., Biswanath, S., Farr, C.-M., Lupanow, V., Teske, J., Ritzenhoff, K., Franke, A., Manstein, F., Bolesani, E., Kempf, H., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00815-9 · Cited by 452 · see citing works
Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity
Richards, D. J., Li, Y., Kerr, C. M., Yao, J., Beeson, G. C., Coyle, R. C., Chen, X., Jia, J., Damon, B., Wilson, R., et al. (2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0539-4 · Cited by 439 · see citing works
NKX2-5eGFP/w hESCs for isolation of human cardiac progenitors and cardiomyocytes
Elliott, D. A., Braam, S. R., Koutsis, K., Ng, E. S., Jenny, R., Lagerqvist, E. L., Biben, C., Hatzistavrou, T., Hirst, C. E., Yu, Q. C., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1740 · Cited by 426 · see citing works
The Multiple Phases and Faces of Wnt Signaling During Cardiac Differentiation and Development
Gessert, S., & Kühl, M. (2010) · Circulation Research · doi:10.1161/circresaha.110.221531 · Cited by 413 · see citing works
Crespo, M., Vilar, E., Tsai, S.-Y., Chang, K., Amin, S., Srinivasan, T., Zhang, T., Pipalia, N. H., Chen, H. J., Witherspoon, M., et al. (2017) · Nature Medicine · doi:10.1038/nm.4355 · Cited by 399 · see citing works
Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes
Braam, S. R., Tertoolen, L. G. J., van de Stolpe, A., Meyer, T. S., Passier, R. C., & Mummery, C. L. (2009) · Stem Cell Research · doi:10.1016/j.scr.2009.11.004 · Cited by 369 · see citing works
Kupfer, M. E., Lin, W.-H., Ravikumar, V., Qiu, K., Wang, L., Gao, L., Bhuiyan, D. B., Lenz, M., Ai, J., Mahutga, R. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316155 · Cited by 329 · see citing works
Mills, R. J., Parker, B. L., Quaife-Ryan, G. A., Voges, H. K., Needham, E. J., Bornot, A., Ding, M., Andersson, H., Polla, M., Elliott, D. A., et al. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.03.009 · Cited by 312 · see citing works
Huebsch, N., Loskill, P., Mandegar, M. A., Marks, N. C., Sheehan, A. S., Ma, Z., Mathur, A., Nguyen, T., Yoo, J. C., Judge, L. M., et al. (2014) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2014.0283 · Cited by 308 · see citing works
Capturing Cardiogenesis in Gastruloids
Rossi, G., Broguiere, N., Miyamoto, M., Boni, A., Guiet, R., Girgin, M., Kelly, R. G., Kwon, C., & Lutolf, M. P. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.013 · Cited by 306 · see citing works
Fatty Acids Enhance the Maturation of Cardiomyocytes Derived from Human Pluripotent Stem Cells
Yang, X., Rodriguez, M. L., Leonard, A., Sun, L., Fischer, K. A., Wang, Y., Ritterhoff, J., Zhao, L., Kolwicz, S. C., Pabon, L., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.013 · Cited by 301 · see citing works
Validation of the Cardiosphere Method to Culture Cardiac Progenitor Cells from Myocardial Tissue
Davis, D. R., Zhang, Y., Smith, R. R., Cheng, K., Terrovitis, J., Malliaras, K., Li, T.-S., White, A., Makkar, R., & Marbán, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007195 · Cited by 300 · see citing works
Heart Fields and Cardiac Morphogenesis
Kelly, R. G., Buckingham, M. E., & Moorman, A. F. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a015750 · Cited by 283 · see citing works
Giacomelli, E., Bellin, M., Sala, L., van Meer, B. J., Tertoolen, L. G. J., Orlova, V. V., & Mummery, C. L. (2017) · Development · doi:10.1242/dev.143438 · Cited by 280 · see citing works
Differentiation of cardiomyocytes and generation of human engineered heart tissue
Breckwoldt, K., Letuffe-Brenière, D., Mannhardt, I., Schulze, T., Ulmer, B., Werner, T., Benzin, A., Klampe, B., Reinsch, M. C., Laufer, S., et al. (2017) · Nature Protocols · doi:10.1038/nprot.2017.033 · Cited by 272 · see citing works
Embryonic Heart Progenitors and Cardiogenesis
Brade, T., Pane, L. S., Moretti, A., Chien, K. R., & Laugwitz, K.-L. (2013) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a013847 · Cited by 254 · see citing works
The epicardium as a hub for heart regeneration
Cao, J., & Poss, K. D. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0046-4 · Cited by 236 · see citing works
Li, Q., Nan, K., Le Floch, P., Lin, Z., Sheng, H., Blum, T. S., & Liu, J. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02512 · Cited by 224 · see citing works
What is a normal blood glucose?
Güemes, M., Rahman, S. A., & Hussain, K. (2015) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-308336 · Cited by 223 · see citing works
Self-organizing human cardiac microchambers mediated by geometric confinement
Ma, Z., Wang, J., Loskill, P., Huebsch, N., Koo, S., Svedlund, F. L., Marks, N. C., Hua, E. W., Grigoropoulos, C. P., Conklin, B. R., et al. (2015) · Nature Communications · doi:10.1038/ncomms8413 · Cited by 214 · see citing works
Subramanian, A., Sidhom, E.-H., Emani, M., Vernon, K., Sahakian, N., Zhou, Y., Kost-Alimova, M., Slyper, M., Waldman, J., Dionne, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13382-0 · Cited by 211 · see citing works
The Role of the Epicardium During Heart Development and Repair
Quijada, P., Trembley, M. A., & Small, E. M. (2020) · Circulation Research · doi:10.1161/circresaha.119.315857 · Cited by 201 · see citing works
Kitani, T., Ong, S.-G., Lam, C. K., Rhee, J.-W., Zhang, J. Z., Oikonomopoulos, A., Ma, N., Tian, L., Lee, J., Telli, M. L., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037357 · Cited by 200 · see citing works
Bargehr, J., Ong, L. P., Colzani, M., Davaapil, H., Hofsteen, P., Bhandari, S., Gambardella, L., Le Novère, N., Iyer, D., Sampaziotis, F., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0197-9 · Cited by 195 · see citing works
Hyperinsulinemia and Macrosomia in the Fetus of the Diabetic Mother
Schwartz, R., Gruppuso, P. A., Petzold, K., Brambilla, D., Hiilesmaa, V., & Teramo, K. A. (1994) · Diabetes Care · doi:10.2337/diacare.17.7.640 · Cited by 193 · see citing works
Identification of Novel Long Noncoding RNAs Underlying Vertebrate Cardiovascular Development
Kurian, L., Aguirre, A., Sancho-Martinez, I., Benner, C., Hishida, T., Nguyen, T. B., Reddy, P., Nivet, E., Krause, M. N., Nelles, D. A., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013303 · Cited by 189 · see citing works
Self-citationGeneration of the epicardial lineage from human pluripotent stem cells
Witty, A. D., Mihic, A., Tam, R. Y., Fisher, S. A., Mikryukov, A., Shoichet, M. S., Li, R.-K., Kattman, S. J., & Keller, G. (2014) · Nature Biotechnology · doi:10.1038/nbt.3002 · Cited by 180 · see citing works
Silva, A. C., Rubio, O., Joy, D. A., Kauss, M. A., Natarajan, V., Lai, M. H., Turaga, D., Blair, A. P., Alexanian, M., Bruneau, B. G., et al. (2021) · Cell stem cell · doi:10.1016/j.stem.2021.11.007 · Cited by 179 · see citing works
Inspiration from heart development: Biomimetic development of functional human cardiac organoids
Richards, D. J., Coyle, R. C., Tan, Y., Jia, J., Wong, K., Toomer, K., Menick, D. R., & Mei, Y. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.07.021 · Cited by 166 · see citing works
Panopoulos, A. D., D’Antonio, M., Benaglio, P., Williams, R. M., Hashem, S. I., Schuldt, B. M., DeBoever, C., Arias, A. D., Garcia, M., Nelson, B., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.03.012 · Cited by 162 · see citing works
Self-citationProtze, S. I., Lee, J. H., & Keller, G. M. (2019) · Cell Stem Cell · doi:10.1016/j.stem.2019.07.010 · Cited by 162 · see citing works
Chemically defined, albumin-free human cardiomyocyte generation
Lian, X., Bao, X., Zilberter, M., Westman, M., Fisahn, A., Hsiao, C., Hazeltine, L. B., Dunn, K. K., Kamp, T. J., & Palecek, S. P. (2015) · Nature Methods · doi:10.1038/nmeth.3448 · Cited by 159 · see citing works
Hoang, P., Wang, J., Conklin, B. R., Healy, K. E., & Ma, Z. (2018) · Nature Protocols · doi:10.1038/nprot.2018.006 · Cited by 156 · see citing works
In vitro generation of functional murine heart organoids via FGF4 and extracellular matrix
Lee, J., Sutani, A., Kaneko, R., Takeuchi, J., Sasano, T., Kohda, T., Ihara, K., Takahashi, K., Yamazoe, M., Morio, T., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18031-5 · Cited by 154 · see citing works
Bertero, A., Fields, P., Ramani, V., Bonora, G., Yardımcı, G., Reinecke, H., Pabon, L., Noble, W. S., Shendure, J., & Murry, C. (2019) · Nature Communications · doi:10.1038/s41467-019-09483-5 · Cited by 150 · see citing works
Später, D., Hansson, E. M., Zangi, L., & Chien, K. R. (2014) · Development · doi:10.1242/dev.091538 · Cited by 143 · see citing works
Osataphan, N., Phrommintikul, A., Chattipakorn, S. C., & Chattipakorn, N. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15305 · Cited by 141 · see citing works
Precardiac organoids form two heart fields via Bmp/Wnt signaling
Andersen, P., Tampakakis, E., Jimenez, D. V., Kannan, S., Miyamoto, M., Shin, H. K., Saberi, A., Murphy, S., Sulistio, E., Chelko, S. P., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05604-8 · Cited by 132 · see citing works
Origin, development, and differentiation of cardiac fibroblasts
Lajiness, J. D., & Conway, S. J. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2013.11.003 · Cited by 130 · see citing works
Hand2 function in second heart field progenitors is essential for cardiogenesis
Tsuchihashi, T., Maeda, J., Shin, C. H., Ivey, K. N., Black, B. L., Olson, E. N., Yamagishi, H., & Srivastava, D. (2010) · Developmental Biology · doi:10.1016/j.ydbio.2010.12.023 · Cited by 129 · see citing works
Cardiac fibroblasts: from development to heart failure
Moore‐Morris, T., Guimarães‐Camboa, N., Yutzey, K. E., Pucéat, M., & Evans, S. Μ. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1314-y · Cited by 121 · see citing works
N-Acetylcysteine prevents congenital heart defects induced by pregestational diabetes
Moazzen, H., Lu, X., Ma, N. L., Velenosi, T. J., Urquhart, B. L., Wisse, L. J., Gittenberger-de Groot, A. C., & Feng, Q. (2014) · Cardiovascular Diabetology · doi:10.1186/1475-2840-13-46 · Cited by 111 · see citing works
Bao, X., Lian, X. L., Hacker, T. A., Schmuck, E. G., Qian, T., Bhute, V. J., Han, T., Shi, M., Drowley, L., Plowright, A. T., et al. (2016) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0003 · Cited by 107 · see citing works
Barnes, R. M., Firulli, B. A., Conway, S. J., Vincentz, J. W., & Firulli, A. B. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22428 · Cited by 103 · see citing works
Wu, Y., Reece, E. A., Zhong, J., Dong, D., Shen, W.-B., Harman, C. R., & Yang, P. (2016) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2016.03.036 · Cited by 100 · see citing works
Zhang, Q., Schepis, A., Huang, H., Yang, J., Ma, W., Torra, J., Zhang, S., Yang, L., Wu, H., Nonell, S., et al. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.8b13042 · Cited by 90 · see citing works
Hashem, S. I., Perry, C. N., Bauer, M., Han, S. J., Clegg, S. D., Ouyang, K., Deacon, D. C., Spinharney, M., Panopoulos, A. D., Belmonte, J. C. I., et al. (2015) · Stem Cells · doi:10.1002/stem.2015 · Cited by 88 · see citing works
Fetal cardiac hypertrophy and cardiac function in diabetic pregnancies
Gandhi, J. A., Zhang, X. Y., & Maidman, J. E. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)91339-4 · Cited by 87 · see citing works
Cardiac fibroblasts: more than mechanical support
Doppler, S. A., Carvalho, C., Lahm, H., Deutsch, M.-A., Dreßen, M., Puluca, N., Lange, R., & Krane, M. (2017) · Journal of Thoracic Disease · doi:10.21037/jtd.2017.03.122 · Cited by 86 · see citing works
Barnes, R. M., Firulli, B. A., VanDusen, N. J., Morikawa, Y., Conway, S. J., Cserjesi, P., Vincentz, J. W., & Firulli, A. B. (2011) · Circulation Research · doi:10.1161/circresaha.110.233171 · Cited by 82 · see citing works
Discovery and technology for human health
(2017) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0001 · Cited by 82 · see citing works
Dong, Z., Liu, G., Ni, G., Jerwick, J., Duan, L., & Zhou, C. (2020) · Journal of Biophotonics · doi:10.1002/jbio.201960135 · Cited by 78 · see citing works
Self-citationHuman Cardiac Organoids for Modeling Genetic Cardiomyopathy
Buono, M. F., von Boehmer, L., Strang, J., Hoerstrup, S. P., Emmert, M. Y., & Nugraha, B. (2020) · Cells · doi:10.3390/cells9071733 · Cited by 72 · see citing works
Hand Factors in Cardiac Development
George, R. M., & Firulli, A. B. (2019) · The Anatomical Record · doi:10.1002/ar.23910 · Cited by 68 · see citing works
Feng, W. H., Schriever, H. C., Jiang, S., Bais, A. S., Wu, H., Kostka, D., & Li, G. (2022) · Communications Biology · doi:10.1038/s42003-022-03346-4 · Cited by 68 · see citing works
Jackson, S. A., Schiesser, J., Stanley, E. G., & Elefanty, A. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010706 · Cited by 67 · see citing works
Human heart disease: lessons from human pluripotent stem cell-derived cardiomyocytes
Giacomelli, E., Mummery, C. L., & Bellin, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2546-5 · Cited by 60 · see citing works
A complete workflow for the differentiation and the dissociation of hiPSC-derived cardiospheres
Fischer, B., Meier, A., Dehne, A., Salhotra, A., Tran, T. A., Neumann, S., Schmidt, K., Meiser, I., Neubauer, J. C., Zimmermann, H., et al. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.08.015 · Cited by 50 · see citing works
Titmarsh, D. M., Hudson, J. E., Hidalgo, A., Elefanty, A. G., Stanley, E. G., Wolvetang, E. J., & Cooper-White, J. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052405 · Cited by 48 · see citing works
Luma is not essential for murine cardiac development and function
Stroud, M. J., Fang, X., Zhang, J., Guimarães‐Camboa, N., Veevers, J., Dalton, N. D., Gu, Y., Bradford, W. H., Peterson, K. L., Evans, S. Μ., et al. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx205 · Cited by 45 · see citing works
Dunn, K. K., & Palecek, S. P. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00110 · Cited by 41 · see citing works
Activin-A and Bmp4 Levels Modulate Cell Type Specification during CHIR-Induced Cardiomyogenesis
Kim, M.-S., Horst, A., Blinka, S., Stamm, K., Mahnke, D., Schuman, J., Gundry, R., Tomita-Mitchell, A., & Lough, J. (2015) · PLOS ONE · doi:10.1371/journal.pone.0118670 · Cited by 38 · see citing works
Heart disease in infants of diabetic mothers.
Narchı, H., & Kulaylat, N. A. (2000) · PubMed · Cited by 35 · see citing works
Developmental co-emergence of cardiac and gut tissues modeled by human iPSC-derived organoidsPreprint
Silva, A. C., Rubio, O., Joy, D. A., Kauss, M. A., Natarajan, V., Lai, M. H., Turaga, D., Blair, A. P., Alexanian, M., Bruneau, B. G., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.30.071472 · Cited by 21 · see citing works
Generating Self-Assembling Human Heart Organoids Derived from Pluripotent Stem Cells
Lewis‐Israeli, Y. R., Volmert, B. D., Gabalski, M. A., Huang, A., & Aguirre, A. (2021) · Journal of Visualized Experiments · doi:10.3791/63097 · Cited by 19 · see citing works
Self-citation(2012) · Journal of Stem Cells and Regenerative Medicine · doi:10.46582/jsrm.0803013 · Cited by 13 · see citing works
Béghin, A., Grenci, G., Rajendiran, H., Delaire, T., Raffi, S. B. M., Blanc, D., Mets, R. D. M. D., Ong, H. T., Acharya, V., Sahini, G., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.26.437121 · Cited by 12 · see citing works
Feng, W. H., Schriever, H. C., Jiang, S., Bais, A. S., Kostka, D., & Li, G. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.24.424346 · Cited by 3 · see citing works
Generation of self-assembling heart organoids from human pluripotent stem cellsPreprint
Lewis‐Israeli, Y. R., Volmert, B. D., Gabalski, M. A., Huang, A., & Aguirre, A. (2022) · Research Square · doi:10.21203/rs.3.pex-1589/v1 · Cited by 3 · see citing works
Self-citationHuman Vascularised Cardiac Organoids for Disease Modelling
Lees, J. G., Kong, A. M., Mitchell, G. M., & Lim, S. Y. (2019) · Heart Lung and Circulation · doi:10.1016/j.hlc.2019.06.193 · Cited by 2 · see citing works
Yang, W., Fan, Q. H., & Li, W. (2020) · IEEE International Conference on Nano/Micro Engineered and Molecular Systems · doi:10.1109/nems50311.2020.9265573 · Cited by 2 · see citing works
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- Scott F. & Gilbert, M. J. F. B. Lateral Plate Mesoderm: Heart and Circulatory System. In Developmental Biology 591–610 (Sinauer Associates is an imprint of Oxford University Press, 2019).
- Eilers, P. H., & Boelens, H. F. Baseline correction with asymmetric least squares smoothing. Leiden University Medical Centre Report. 1, 5 (2005).
Cited by
Sorted by citations
Vascular endothelial cell development and diversity
Trimm, E., & Red-Horse, K. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00770-1 · Cited by 537 · see citing works
Organoids: The current status and biomedical applications
Yang, S., Hu, H., Kung, H., Zou, R.-Q., Dai, Y.-S., Hu, Y.-F., Wang, T., Lv, T., Yu, J., & Li, F. (2023) · MedComm · doi:10.1002/mco2.274 · Cited by 282 · see citing works
Three-Dimensional Cell Cultures: The Bridge between In Vitro and In Vivo Models
Urzì, O., Gasparro, R., Costanzo, E., Luca, A. D., Giavaresi, G., Fontana, S., & Alessandro, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512046 · Cited by 247 · see citing works
Microfluidic organoids-on-a-chip: The future of human models
Saorin, G., Caligiuri, I., & Rizzolio, F. (2022) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2022.10.001 · Cited by 206 · see citing works
Integrating organoids and organ-on-a-chip devices
Zhao, Y., Landau, S., Okhovatian, S., Liu, C., Lu, R. X. Z., Lai, B. F. L., Wu, Q., Kieda, J., Cheung, K., Rajasekar, S., et al. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00207-z · Cited by 206 · see citing works
Challenges and opportunities for the next generation of cardiovascular tissue engineering
Cho, S., Discher, D. E., Leong, K. W., Vunjak-Novakovic, G., & Wu, J. C. (2022) · Nature Methods · doi:10.1038/s41592-022-01591-3 · Cited by 176 · see citing works
Human organoids: New strategies and methods for analyzing human development and disease
Corsini, N. S., & Knoblich, J. A. (2022) · Cell · doi:10.1016/j.cell.2022.06.051 · Cited by 171 · see citing works
Progress in multicellular human cardiac organoids for clinical applications
Kim, H., Kamm, R. D., Vunjak‐Novakovic, G., & Wu, J. C. (2022) · Cell stem cell · doi:10.1016/j.stem.2022.03.012 · Cited by 153 · see citing works
Vascular cells improve functionality of human cardiac organoids
Voges, H. K., Foster, S. R., Reynolds, L., Parker, B. L., Devilée, L., Quaife-Ryan, G. A., Fortuna, P. R. J., Mathieson, E., Fitzsimmons, R., Lor, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112322 · Cited by 139 · see citing works
Human organoids-on-chips for biomedical research and applications
Wang, H., Ning, X., Zhao, F. H., Zhao, H., & Li, D. (2024) · Theranostics · doi:10.7150/thno.90492 · Cited by 138 · see citing works
Human pluripotent-stem-cell-derived organoids for drug discovery and evaluation
Vandana, J. J., Manrique, C., Lacko, L. A., & Chen, S. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.04.011 · Cited by 132 · see citing works
Volmert, B. D., Kiselev, A. M., Juhong, A., Wang, F., Riggs, A., Kostina, A. S., O’Hern, C., Muniyandi, P., Wasserman, A. H., Huang, A., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43999-1 · Cited by 117 · see citing works
Self-citationAdvanced 3D imaging and organoid bioprinting for biomedical research and therapeutic applications
Maharjan, S., Ma, C., Singh, B., Kang, H., Orive, G., Yao, J., & Zhang, Y. S. (2024) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2024.115237 · Cited by 105 · see citing works
Min, S., Kim, S., Sim, W., Choi, Y. S., Joo, H., Park, J.-H., Lee, S.-J., Kim, H., Lee, M. J., Jeong, I., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46928-y · Cited by 103 · see citing works
The molecular mechanisms of cardiac development and related diseases
Li, Y., Du, J., Deng, S., Liu, B., Jing, X., Yan, Y., Liu, Y., Wang, J., Zhou, X., & She, Q. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02069-8 · Cited by 103 · see citing works
Zhu, M., Zhang, H., Zhou, Q., Sheng, S., Gao, Q., Geng, Z., Chen, X., Lai, Y., Jing, Y., Xu, K., et al. (2025) · Advanced Materials · doi:10.1002/adma.202501254 · Cited by 101 · see citing works
Ergir, E., Oliver-De La Cruz, J., Fernandes, S., Cassani, M., Niro, F., Pereira-Sousa, D., Vrbský, J., Vinarský, V., Perestrelo, A. R., Debellis, D., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-22225-w · Cited by 99 · see citing works
Prondzynski, M., Berkson, P., Trembley, M. A., Tharani, Y., Shani, K., Bortolin, R. H., Sweat, M., Mayourian, J., Yücel, D., Cordoves, A. M., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50224-0 · Cited by 99 · see citing works
Landscape of human organoids: Ideal model in clinics and research
Han, X., Cai, C., Deng, W., Shi, Y., Li, L., Wang, C., Zhang, J., Rong, M., Liu, J., Fang, B., et al. (2024) · The Innovation · doi:10.1016/j.xinn.2024.100620 · Cited by 98 · see citing works
Gastruloids enable modeling of the earliest stages of human cardiac and hepatic vascularization
Abilez, O. J., Yang, H., Guan, Y., Shen, M., Yıldırım, Z., Zhuge, Y., Venkateshappa, R., Zhao, S. R., Gomez, A. H., El‐Mokahal, M., et al. (2025) · Science · doi:10.1126/science.adu9375 · Cited by 99 · see citing works
Yao, Q., Cheng, S., Pan, Q., Yu, J., Cao, G., Li, L., & Cao, H. (2024) · MedComm · doi:10.1002/mco2.735 · Cited by 97 · see citing works
Organoid bioprinting: from cells to functional tissues
Huang, M. S., Christakopoulos, F., Roth, J. G., & Heilshorn, S. C. (2024) · Nature Reviews Bioengineering · doi:10.1038/s44222-024-00268-0 · Cited by 96 · see citing works
Cellular and Engineered Organoids for Cardiovascular Models
Thomas, D., Choi, S., Alamana, C., Parker, K. K., & Wu, J. C. (2022) · Circulation Research · doi:10.1161/circresaha.122.320305 · Cited by 95 · see citing works
Revolutionizing Disease Modeling: The Emergence of Organoids in Cellular Systems
Silva-Pedrosa, R., Salgado, A. J., & Ferreira, P. E. (2023) · Cells · doi:10.3390/cells12060930 · Cited by 84 · see citing works
Generation of human iPSCs derived heart organoids structurally and functionally similar to heart
Lee, S., Kim, Y., Son, M., Oh, M.-S., Kim, J., Ryu, B., Kang, K.-R., Baek, J., Chung, G., Woo, D. H., et al. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121860 · Cited by 80 · see citing works
Yang, J., Lei, W., Xiao, Y., Tan, S., Yang, J., Lin, Y., Yang, Z., Zhao, D., Zhang, C., Shen, Z., et al. (2024) · Cell Proliferation · doi:10.1111/cpr.13631 · Cited by 75 · see citing works
Múnera, J. O., Kechele, D. O., Bouffi, C., Qu, N., Jing, R., Maity, P. P., Enriquez, J. R., Han, L., Campbell, I., Mahé, M. M., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.10.002 · Cited by 73 · see citing works
Ming, Y., Hao, S., Wang, F., Lewis‐Israeli, Y. R., Volmert, B. D., Xu, Z., Goestenkors, A. P., Aguirre, A., & Zhou, C. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114136 · Cited by 68 · see citing works
Self-citationFeng, W. H., Schriever, H. C., Jiang, S., Bais, A. S., Wu, H., Kostka, D., & Li, G. (2022) · Communications Biology · doi:10.1038/s42003-022-03346-4 · Cited by 68 · see citing works
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
Nicholson, M. W., Ting, C.-Y., Chan, D. Z. H., Cheng, Y.-C., Lee, Y.-C., Hsu, C.-C., Huang, C.-Y., & Hsieh, P. C. H. (2022) · Cells · doi:10.3390/cells11111853 · Cited by 66 · see citing works
“Self-assembling human cardiac organoids have also been used to show the role of BMP4 and Activin A to improve heart organoid chamber formation and vascularization [60].”
MethodFrom engineered heart tissue to cardiac organoid
Cho, J., Lee, H., Rah, W., Chang, H., & Yoon, Y. (2022) · Theranostics · doi:10.7150/thno.67661 · Cited by 66 · see citing works
Kim, D., Lim, H., Youn, J., Park, T., & Kim, D. S. (2024) · Nature Communications · doi:10.1038/s41467-024-53073-z · Cited by 65 · see citing works
Cellular interplay between cardiomyocytes and non-myocytes in diabetic cardiomyopathy
Phang, R. J., Ritchie, R. H., Hausenloy, D. J., Lees, J. G., & Lim, S. Y. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac049 · Cited by 65 · see citing works
Hamidzada, H., Pascual‐Gil, S., Wu, Q., Kent, G. M., Massé, S., Kantores, C., Kuzmanov, U., Gomez-Garcia, M. J., Rafatian, N., Gorman, R. A., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00471-7 · Cited by 62 · see citing works
Rapid and scalable personalized ASO screening in patient-derived organoids
Means, J. C., Martinez‐Bengochea, A., Louiselle, D. A., Nemechek, J. M., Perry, J. M., Farrow, E., Pastinen, T., & Younger, S. T. (2025) · Nature · doi:10.1038/s41586-024-08462-1 · Cited by 62 · see citing works
Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models
Mohr, E., Thum, T., & Bär, C. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2631 · Cited by 59 · see citing works
Yang, X., Chen, D., Sun, Q., Wang, Y., Xia, Y., Yang, J., Lin, C., Dang, X., Cen, Z., Liang, D., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00543-1 · Cited by 58 · see citing works
Generating 3D human cardiac constructs from pluripotent stem cells
Liu, C., Feng, X., Li, G., Gokulnath, P., & Xiao, J. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103813 · Cited by 57 · see citing works
Dynamic contrast optical coherence tomography (DyC-OCT) for label-free live cell imaging
Ren, C., Hao, S., Wang, F., Matt, A., Amaral, M. M., Yang, D. Z., Wang, L., & Zhou, C. (2024) · Communications Biology · doi:10.1038/s42003-024-05973-5 · Cited by 57 · see citing works
Self-citationLewis‐Israeli, Y. R., Wasserman, A. H., & Aguirre, A. (2021) · Biomolecules · doi:10.3390/biom11091277 · Cited by 56 · see citing works
Self-citationZhang, T., Yang, S., Ge, Y., Yin, L., Pu, Y., Gu, Z., Chen, Z., & Liang, G. (2024) · ACS Nano · doi:10.1021/acsnano.4c13262 · Cited by 56 · see citing works
From organoids to organoids-on-a-chip: Current applications and challenges in biomedical research
Liu, K., Chen, X., Fan, Z., Ren, F., Liu, J., & Hu, B. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003535 · Cited by 56 · see citing works
Functional genomics and the future of iPSCs in disease modeling
Brooks, I. R., Garrone, C. M., Kerins, C., Kiar, C. S., Syntaka, S., Xu, J. Z., Spagnoli, F. M., & Watt, F. M. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.03.019 · Cited by 54 · see citing works
Embryonic exposure of polystyrene nanoplastics affects cardiac development
Li, J., Weng, H., Liu, S., Li, F., Xu, K., Wen, S., Chen, X., Li, C., Nie, Y., Liao, B., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167406 · Cited by 54 · see citing works
Spatial confinement toward creating artificial living systems
Shang, L., Ye, F., Li, M., & Zhao, Y. (2022) · Chemical Society Reviews · doi:10.1039/d1cs01025e · Cited by 53 · see citing works
Yang, H., Yang, Y., Kiskin, F. N., Shen, M., & Zhang, J. Z. (2023) · Stem Cell Research & Therapy · doi:10.1186/s13287-023-03470-w · Cited by 52 · see citing works
Organoids from pluripotent stem cells and human tissues: When two cultures meet each other
Artegiani, B., & Hendriks, D. F. G. (2025) · Developmental Cell · doi:10.1016/j.devcel.2025.01.005 · Cited by 52 · see citing works
Branco, M. A., Dias, T. P., Cabral, J. M. S., Pinto‐do‐Ó, P., & Diogo, M. M. (2022) · Nature Communications · doi:10.1038/s41467-022-34730-7 · Cited by 51 · see citing works
Merits and challenges of iPSC-derived organoids for clinical applications
Xu, Z., Yang, J., Xin, X., Liu, C., Li, L., Mei, X., & Li, M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1188905 · Cited by 51 · see citing works
Wu, X., Chen, Y., Luz, A. L., Hu, G., & Tokar, E. J. (2022) · Environmental Health Perspectives · doi:10.1289/ehp11208 · Cited by 50 · see citing works
Multi-omics profiling visualizes dynamics of cardiac development and functions
Gu, Y., Zhou, Y., Ju, S., Liu, X., Zhang, Z., Guo, J., Gao, J., Zang, J., Sun, H., Chen, Q., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111891 · Cited by 49 · see citing works
Lin, Z., Garbern, J. C., Liu, R., Li, Q., Juncosa, E. M., Elwell, H., Sokol, M. K., Aoyama, J., Deumer, U.-S., Hsiao, E., et al. (2023) · Science Advances · doi:10.1126/sciadv.ade8513 · Cited by 48 · see citing works
Engineering approaches for cardiac organoid formation and their characterization
Joddar, B., Natividad-Diaz, S. L., Padilla, A. E., Esparza, A., Ramirez, S. P., Chambers, D. R., & Ibaroudene, H. (2022) · Translational research · doi:10.1016/j.trsl.2022.08.009 · Cited by 47 · see citing works
Recent Advances in Generation of In Vitro Cardiac Organoids
Sahara, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076244 · Cited by 47 · see citing works
Chen, X., Lu, N., Huang, S., Zhang, Y., Liu, Z., & Wang, X. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110777 · Cited by 47 · see citing works
van Loo, B., ten Den, S. A., Araújo‐Gomes, N., de Jong, V., Snabel, R. R., Schot, M., Rivera‐Arbeláez, J. M., Veenstra, G. J. C., Passier, R. C., Kamperman, T., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-42297-0 · Cited by 44 · see citing works
Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells
Fernandes, I. M., Funakoshi, S., Hamidzada, H., Epelman, S., & Keller, G. M. (2023) · Nature Communications · doi:10.1038/s41467-023-43312-0 · Cited by 44 · see citing works
Novelli, G., Spitalieri, P., Murdocca, M., Centanini, E., & Sangiuolo, F. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1059579 · Cited by 43 · see citing works
“developed heart organoids that mimic the cardiac structure, reflecting the vascular network inside the organoid without external interference (Lewis-Israeli et al., 2021).”
BackgroundZheng, Z., Zhu, S., Lv, M., Gu, Z., & Hu, H. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101453 · Cited by 42 · see citing works
Recent Advances in Electrophysiological Recording Platforms for Brain and Heart Organoids
Chung, W. G., Kim, E., Song, H., Lee, J., Lee, S., Lim, K., Jeong, I., & Park, J. (2022) · Advanced NanoBiomed Research · doi:10.1002/anbr.202200081 · Cited by 41 · see citing works
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem‐cell‐derived organoids
Tolle, I., Tiranti, V., & Prigione, A. (2023) · EMBO Reports · doi:10.15252/embr.202255678 · Cited by 40 · see citing works
Clinical trials in-a-dish for cardiovascular medicine
Wu, X., Swanson, K., Yıldırım, Z., Liu, W., Liao, R., & Wu, J. C. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae519 · Cited by 40 · see citing works
Yıldırım, Z., Swanson, K., Wu, X., Zou, J., & Wu, J. C. (2024) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-022724-095035 · Cited by 39 · see citing works
Self-citationAdvances in 3D Bioprinted Cardiac Tissue Using Stem Cell-Derived Cardiomyocytes
Bliley, J. M., Stang, M. A., Behre, A., & Feinberg, A. W. (2024) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szae014 · Cited by 38 · see citing works
Maturation of human cardiac organoids enables complex disease modeling and drug discovery
Pocock, M. W., Reid, J. D., Robinson, H., Charitakis, N., Krycer, J. R., Foster, S. R., Fitzsimmons, R. L., Lor, M., Devilée, L., Batho, C. A. P., et al. (2025) · Nature Cardiovascular Research · doi:10.1038/s44161-025-00669-3 · Cited by 38 · see citing works
Kim, D., Youn, J., Kim, J., Lee, J., Yoon, J., & Kim, D. S. (2026) · npj Biomedical Innovations. · doi:10.1038/s44385-025-00054-6 · Cited by 39 · see citing works
O’Hern, C., Caywood, S., Aminova, S., Kiselev, A. M., Volmert, B. D., Cao, W., Wang, F., Dionise, M., Sewavi, M.-L., Skoric, M., et al. (2025) · Cell stem cell · doi:10.1016/j.stem.2025.09.011 · Cited by 37 · see citing works
Self-citationKostina, A. S., Lewis‐Israeli, Y. R., Abdelhamid, M., Gabalski, M. A., Kiselev, A. M., Volmert, B. D., Lankerd, H., Huang, A., Wasserman, A. H., Lydic, T. A., et al. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.01.003 · Cited by 36 · see citing works
Self-citationImaging 3D cell cultures with optical microscopy
Hsieh, H.-C., Han, Q., Brenes, D., Bishop, K. W., Wang, R., Wang, Y., Poudel, C., Glaser, A. K., Freedman, B., Vaughan, J. C., et al. (2025) · Nature Methods · doi:10.1038/s41592-025-02647-w · Cited by 36 · see citing works
Zhu, Y., Jiang, D., Qiu, Y. L., Liu, X., Bian, Y., Tian, S., Wang, X., Hsia, K. J., Wan, H., Zhuang, L., et al. (2024) · Bioactive Materials · doi:10.1016/j.bioactmat.2024.05.019 · Cited by 35 · see citing works
Endometrial organoids: a reservoir of functional mitochondria for uterine repair
Hwang, S., Lee, D., Lee, G., Ahn, J., Lee, Y., Koo, H. S., & Kang, Y. (2024) · Theranostics · doi:10.7150/thno.90538 · Cited by 34 · see citing works
Microphysiological Systems as Organ-Specific In Vitro Vascular Models for Disease Modeling
Nam, U., Lee, S., Ahmad, A., Yi, H., & Jeon, J. S. (2024) · BioChip Journal · doi:10.1007/s13206-024-00152-4 · Cited by 34 · see citing works
Human cardiac organoids to model COVID‐19 cytokine storm induced cardiac injuries
Arhontoulis, D. C., Kerr, C. M., Richards, D., Tjen, K., Hyams, N. A., Jones, J. A., DeLeon‐Pennell, K. Y., Menick, D. R., Bräuninger, H., Lindner, D., et al. (2022) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1002/term.3327 · Cited by 34 · see citing works
Zawada, D. M., Kornherr, J., Meier, A. B., Santamaria, G., Dorn, T., Nowak‐Imialek, M., Ortmann, D., Zhang, F., Lachmann, M., Dreßen, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36764-x · Cited by 34 · see citing works
Gene expression in organoids: an expanding horizon
Smirnov, A., Melino, G., & Candi, E. (2023) · Biology Direct · doi:10.1186/s13062-023-00360-2 · Cited by 33 · see citing works
Yang, P., Zhu, L., Wang, S., Gong, J., Selvaraj, J. N., Ye, L., Chen, H., Zhang, Y., Wang, G., Song, W., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-52221-9 · Cited by 33 · see citing works
Insights on Three Dimensional Organoid Studies for Stem Cell Therapy in Regenerative Medicine
Mulaudzi, P. E., Abrahamse, H., & Crous, A. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10655-6 · Cited by 32 · see citing works
Yin, J., Lees, J. G., Gong, S. P., Nguyen, J. T., Phang, R. J., Shi, Q., Huang, Y., Kong, A. M., Dyson, J. M., Lim, S. Y., et al. (2024) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2024.116752 · Cited by 31 · see citing works
Narrative review of single ventricle: where are we after 40 years?
Corno, A. F., Findley, T. O., & Salazar, J. D. (2023) · Translational Pediatrics · doi:10.21037/tp-22-573 · Cited by 31 · see citing works
Human induced pluripotent stem cell-derived planar neural organoids assembled on synthetic hydrogels
Majumder, J., Torr, E., Aisenbrey, E. A., Lebakken, C. S., Favreau, P. F., Richards, W. D., Yin, Y., Chang, Q., & Murphy, W. L. (2024) · Journal of Tissue Engineering · doi:10.1177/20417314241230633 · Cited by 30 · see citing works
Zhang, L., Jiang, Y. Y., Jia, W., Le, W., Liu, J., Zhang, P., Yang, H., Liu, Z., & Liu, Y. (2024) · Cell Proliferation · doi:10.1111/cpr.13762 · Cited by 30 · see citing works
Kim, K., Lee, Y., Jung, K. B., Kim, Y., Jang, E., Lee, M., Son, M., & Lee, H. J. (2024) · Advanced Materials · doi:10.1002/adma.202412953 · Cited by 30 · see citing works
Advances in cardiac organoid research: implications for cardiovascular disease treatment
Huang, Z., Jia, K., Tan, Y., Yang, Y. P., Xiao, W., Zhou, X., Yi, J., & Zhang, C. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02598-8 · Cited by 30 · see citing works
Maternal Pre-Existing Diabetes: A Non-Inherited Risk Factor for Congenital Cardiopathies
Ibrahim, S., Gaborit, B., Lenoir, M., Collod‐Béroud, G., & Stefanovic, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216258 · Cited by 29 · see citing works
Modeling Human Gonad Development in Organoids
Pryzhkova, M. V., Boers, R., & Jordan, P. W. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00492-y · Cited by 29 · see citing works
Yang, J., Zhang, X., Liu, Z., Yang, C., Li, S., Zhou, H., & Gao, Z. (2024) · Chemical Engineering Journal · doi:10.1016/j.cej.2024.155882 · Cited by 28 · see citing works
Bioengineering Strategies to Create 3D Cardiac Constructs from Human Induced Pluripotent Stem Cells
Varzideh, F., Mone, P., & Santulli, G. (2022) · Bioengineering · doi:10.3390/bioengineering9040168 · Cited by 28 · see citing works
Oxytocin promotes epicardial cell activation and heart regeneration after cardiac injury
Wasserman, A. H., Huang, A., Lewis‐Israeli, Y. R., Dooley, M. D., Mitchell, A. L., Venkatesan, M., & Aguirre, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.985298 · Cited by 28 · see citing works
Self-citationSebastian, J. A., Strohm, E. M., Baranger, J., Villemain, O., Kolios, M. C., & Simmons, C. A. (2023) · Biomaterials · doi:10.1016/j.biomaterials.2023.122054 · Cited by 28 · see citing works
Deep learning based characterization of human organoids using optical coherence tomography
Wang, B., Ganjee, R., Khandaker, I., Flohr, K., He, Y., Li, G., Wesalo, J. S., Sahel, J., da Silva, S., & Pi, S. (2024) · Biomedical Optics Express · doi:10.1364/boe.515781 · Cited by 27 · see citing works
Cardiac organoids: a new tool for disease modeling and drug screening applications
Yaqinuddin, A., Jabri, A., Mhannayeh, A., Taftafa, B., Alsharif, M., Abbad, T., Khan, J. A., Elsalti, A., Chinnappan, R., Alshehri, E. A., et al. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1537730 · Cited by 27 · see citing works
Cofiño‐Fabrés, C., Boonen, T., Rivera‐Arbeláez, J. M., Rijpkema, M., Blauw, L. L., Rensen, P. C. N., Schwach, V., Ribeiro, M. C., & Passier, R. C. (2024) · Advanced Healthcare Materials · doi:10.1002/adhm.202303664 · Cited by 26 · see citing works
Ge, J.-Y., Wang, Y., Li, Q., Liu, F.-K., Lei, Q.-K., & Zheng, Y. (2024) · PeerJ · doi:10.7717/peerj.18422 · Cited by 25 · see citing works
Senolytics rejuvenate aging cardiomyopathy in human cardiac organoids
Scalise, M., Cianflone, E., Quercia, C., Pagano, L., Chiefalo, A., Stincelli, A., Torella, A., Puccio, B., Santamaria, G., Guzzi, H. P., et al. (2024) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2024.112007 · Cited by 25 · see citing works
Ni, B., Ye, L., Zhang, Y., Hu, S., & Lei, W. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-06381-x · Cited by 25 · see citing works
Human cardiac organoids: A recent revolution in disease modeling and regenerative medicine
Roshanravan, N., Ghaffari, S., Bastani, S., Pahlavan, S., Asghari, S., Doustvandi, M. A., Razin, S. J., & Dastourı, M. (2023) · Journal of Cardiovascular and Thoracic Research · doi:10.34172/jcvtr.2023.31830 · Cited by 25 · see citing works
Zheng, J., Fang, J., Xu, D., Liu, H., Wei, X., Qin, C., Xue, J., Gao, Z., & Hu, N. (2024) · ACS Nano · doi:10.1021/acsnano.4c00052 · Cited by 24 · see citing works
Endocardial Regulation of Cardiac Development
Feulner, L., Vliet, P. P. V., Pucéat, M., & Andelfinger, G. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9050122 · Cited by 24 · see citing works
Liang, P.-Y., Chang, Y., Jin, G., Lian, X. L., & Bao, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1059243 · Cited by 24 · see citing works
- Authors
- Lewis-Israeli, Y. R., Wasserman, A. H., Gabalski, M. A., Volmert, B. D., Ming, Y., Ball, K. A., Yang, W., Zou, J., Ni, G., Pajares, N., Chatzistavrou, X., Li, W., Zhou, C., & Aguirre, A.
- Affiliations
- Michigan State University (US)
- Washington University in St. Louis (US)
- ORCID
- Venue
- Nature Communications
- Published
- 2021-08-26
- Volume
- 12
- Issue
- 1
- Pages
- 5142-5142
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC8390749
- OpenAlex
- W3113822795
- Semantic Scholar
- 91a81864d4ccfc2cf918084c7bfec9df49ea139c
- Cited by
- 536
- References
- 95
- Citations by year
- 2026: 128 · 2025: 126 · 2024: 106 · 2023: 86 · 2022: 81 · 2021: 8 · 2020: 1
- FWCI
- 21.94
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Health Research Alliance (cc-by)
- Funders
- American Heart Association (19IPLOI34660342)
- U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K01HL135464, R01EB025209)
- National Science Foundation (ECCS-2024270)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Keywords
- self-assembly, heart development, congenital heart disease, human pluripotent stem cells, cardiac vasculature, pregestational diabetes, in vitro disease model
- MeSH terms
- Cell Differentiation, Female, Heart, Heart Defects, Congenital, Humans, Male, Organoids, Pluripotent Stem Cells, Wnt Signaling Pathway
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-07.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-07.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review